activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1483097	CHEMBL835535	Percentage inhibition of Protein kinase C iota at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	87.0	CHEMBL2598	Homo sapiens	Activity	%	87.0
	1483097	CHEMBL835535	Percentage inhibition of Protein kinase C iota at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	87.0	CHEMBL2598	Homo sapiens	Activity	%	87.0
	1483109	CHEMBL835535	Percentage inhibition of Protein kinase C iota at 50 uM	B	CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O		CHEMBL365337	=	Activity	%	96.0	CHEMBL2598	Homo sapiens	Activity	%	96.0
	1680051	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1O		CHEMBL382128	=	Inhibition	%	103.0	CHEMBL2598	Homo sapiens	Inhibition	%	103.0
	1680052	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1O		CHEMBL382128	=	Inhibition	%	93.0	CHEMBL2598	Homo sapiens	Inhibition	%	93.0
	1680369	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL202378	=	Inhibition	%	80.0	CHEMBL2598	Homo sapiens	Inhibition	%	80.0
	1680370	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc2[nH]c3c4c(OC)c(OC)c(OC)cc4c4c(c3c2c1)C(=O)NC4=O		CHEMBL201090	=	Inhibition	%	85.0	CHEMBL2598	Homo sapiens	Inhibition	%	85.0
	1680371	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21		CHEMBL421087	=	Inhibition	%	98.0	CHEMBL2598	Homo sapiens	Inhibition	%	98.0
	1680372	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc2c3c(c4c5ccccc5[nH]c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL380898	=	Inhibition	%	78.0	CHEMBL2598	Homo sapiens	Inhibition	%	78.0
	1680373	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cc4ccccc4[nH]3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL202501	=	Inhibition	%	83.0	CHEMBL2598	Homo sapiens	Inhibition	%	83.0
	1680374	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cccc2ccccc12		CHEMBL202196	=	Inhibition	%	77.0	CHEMBL2598	Homo sapiens	Inhibition	%	77.0
	1680375	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c(-c4ccccc4)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL371449	=	Inhibition	%	81.0	CHEMBL2598	Homo sapiens	Inhibition	%	81.0
	1680376	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c(C)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201463	=	Inhibition	%	78.0	CHEMBL2598	Homo sapiens	Inhibition	%	78.0
	1680377	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201708	=	Inhibition	%	93.0	CHEMBL2598	Homo sapiens	Inhibition	%	93.0
	1680378	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc2[nH]cc(C3=C(c4cc(OC)c(OC)c(OC)c4)C(=O)NC3=O)c2c1		CHEMBL446182	=	Inhibition	%	85.0	CHEMBL2598	Homo sapiens	Inhibition	%	85.0
	1680379	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccc(Cl)cc1		CHEMBL371025	=	Inhibition	%	84.0	CHEMBL2598	Homo sapiens	Inhibition	%	84.0
	1680380	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL201264	=	Inhibition	%	79.0	CHEMBL2598	Homo sapiens	Inhibition	%	79.0
	1680381	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1		CHEMBL202504	=	Inhibition	%	77.0	CHEMBL2598	Homo sapiens	Inhibition	%	77.0
	1680382	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1		CHEMBL380598	=	Inhibition	%	95.0	CHEMBL2598	Homo sapiens	Inhibition	%	95.0
	1680383	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3cc[nH]c3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201512	=	Inhibition	%	92.0	CHEMBL2598	Homo sapiens	Inhibition	%	92.0
	1680384	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	Inhibition	%	81.0	CHEMBL2598	Homo sapiens	Inhibition	%	81.0
	1680385	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccc(OC)cc3)C(=O)NC2=O)cc1		CHEMBL381099	=	Inhibition	%	95.0	CHEMBL2598	Homo sapiens	Inhibition	%	95.0
	1680386	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	O=C1NC(=O)C(c2ccccc2)=C1c1ccccc1		CHEMBL201949	=	Inhibition	%	97.0	CHEMBL2598	Homo sapiens	Inhibition	%	97.0
	1680387	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1		CHEMBL372076	=	Inhibition	%	102.0	CHEMBL2598	Homo sapiens	Inhibition	%	102.0
	1680388	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1OC		CHEMBL202135	=	Inhibition	%	94.0	CHEMBL2598	Homo sapiens	Inhibition	%	94.0
	1680389	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1cc(C2=C(c3ccccc3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL372944	=	Inhibition	%	99.0	CHEMBL2598	Homo sapiens	Inhibition	%	99.0
	1680390	CHEMBL864735	Inhibition of human PKC iota expressed in Sf9 cells at 10 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1		CHEMBL202215	=	Inhibition	%	97.0	CHEMBL2598	Homo sapiens	Inhibition	%	97.0
	1680391	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc2c3c(c4c5ccccc5n(C)c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL202378	=	Inhibition	%	120.0	CHEMBL2598	Homo sapiens	Inhibition	%	120.0
	1680392	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc2[nH]c3c4c(OC)c(OC)c(OC)cc4c4c(c3c2c1)C(=O)NC4=O		CHEMBL201090	=	Inhibition	%	88.0	CHEMBL2598	Homo sapiens	Inhibition	%	88.0
	1680393	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)c2c1c1ccccc1c1[nH]c3ccccc3c21		CHEMBL421087	=	Inhibition	%	111.0	CHEMBL2598	Homo sapiens	Inhibition	%	111.0
	1680394	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc2c3c(c4c5ccccc5[nH]c4c2c(OC)c1OC)C(=O)NC3=O		CHEMBL380898	=	Inhibition	%	96.0	CHEMBL2598	Homo sapiens	Inhibition	%	96.0
	1680395	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cc4ccccc4[nH]3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL202501	=	Inhibition	%	107.0	CHEMBL2598	Homo sapiens	Inhibition	%	107.0
	1680396	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cccc2ccccc12		CHEMBL202196	=	Inhibition	%	68.0	CHEMBL2598	Homo sapiens	Inhibition	%	68.0
	1680397	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c(-c4ccccc4)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL371449	=	Inhibition	%	93.0	CHEMBL2598	Homo sapiens	Inhibition	%	93.0
	1680398	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c(C)[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201463	=	Inhibition	%	90.0	CHEMBL2598	Homo sapiens	Inhibition	%	90.0
	1680399	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201708	=	Inhibition	%	110.0	CHEMBL2598	Homo sapiens	Inhibition	%	110.0
	1680400	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc2[nH]cc(C3=C(c4cc(OC)c(OC)c(OC)c4)C(=O)NC3=O)c2c1		CHEMBL446182	=	Inhibition	%	100.0	CHEMBL2598	Homo sapiens	Inhibition	%	100.0
	1680401	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccc(Cl)cc1		CHEMBL371025	=	Inhibition	%	104.0	CHEMBL2598	Homo sapiens	Inhibition	%	104.0
	1680402	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL201264	=	Inhibition	%	80.0	CHEMBL2598	Homo sapiens	Inhibition	%	80.0
	1680403	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc1		CHEMBL202504	=	Inhibition	%	96.0	CHEMBL2598	Homo sapiens	Inhibition	%	96.0
	1680404	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ccccc1		CHEMBL380598	=	Inhibition	%	96.0	CHEMBL2598	Homo sapiens	Inhibition	%	96.0
	1680405	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3cc[nH]c3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201512	=	Inhibition	%	101.0	CHEMBL2598	Homo sapiens	Inhibition	%	101.0
	1680406	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	Inhibition	%	100.0	CHEMBL2598	Homo sapiens	Inhibition	%	100.0
	1680407	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccc(OC)cc3)C(=O)NC2=O)cc1		CHEMBL381099	=	Inhibition	%	85.0	CHEMBL2598	Homo sapiens	Inhibition	%	85.0
	1680408	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	O=C1NC(=O)C(c2ccccc2)=C1c1ccccc1		CHEMBL201949	=	Inhibition	%	96.0	CHEMBL2598	Homo sapiens	Inhibition	%	96.0
	1680409	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1		CHEMBL372076	=	Inhibition	%	86.0	CHEMBL2598	Homo sapiens	Inhibition	%	86.0
	1680410	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3ccccc3)C(=O)NC2=O)cc1OC		CHEMBL202135	=	Inhibition	%	87.0	CHEMBL2598	Homo sapiens	Inhibition	%	87.0
	1680411	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1cc(C2=C(c3ccccc3)C(=O)NC2=O)cc(OC)c1OC		CHEMBL372944	=	Inhibition	%	82.0	CHEMBL2598	Homo sapiens	Inhibition	%	82.0
	1680412	CHEMBL865899	Inhibition of human PKC iota expressed in Sf9 cells at 100 uM	B	COc1ccc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2=O)cc1		CHEMBL202215	=	Inhibition	%	104.0	CHEMBL2598	Homo sapiens	Inhibition	%	104.0
	1734113	CHEMBL862825	Residual activity at human PKCiota at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	84.0	CHEMBL2598	Homo sapiens	Activity	%	84.0
	1769431	CHEMBL910942	Inhibition of PKCiota	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	uM	1.0
	1790019	CHEMBL854687	Percentage activity of human PKC iota in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	99.0	CHEMBL2598	Homo sapiens	Activity	%	99.0
	2025183	CHEMBL887010	Inhibition of human PKCiota at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	109.0	CHEMBL2598	Homo sapiens	Inhibition	%	109.0
	2025441	CHEMBL887010	Inhibition of human PKCiota at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	85.0	CHEMBL2598	Homo sapiens	Inhibition	%	85.0
	2025442	CHEMBL887010	Inhibition of human PKCiota at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	97.0	CHEMBL2598	Homo sapiens	Inhibition	%	97.0
	2025443	CHEMBL887010	Inhibition of human PKCiota at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	102.0	CHEMBL2598	Homo sapiens	Inhibition	%	102.0
	2147359	CHEMBL922144	Activity of human PKCiota kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	109.0	CHEMBL2598	Homo sapiens	Activity	%	109.0
	2158781	CHEMBL922544	Inhibition of PKCiota	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	>	IC50	nM	40000.0	CHEMBL2598	Homo sapiens	IC50	uM	40.0
	2187198	CHEMBL966813	Inhibition of human PKCiota	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	3463.0	CHEMBL2598	Homo sapiens	IC50	nM	3463.0
	2187199	CHEMBL966813	Inhibition of human PKCiota	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	>	IC50	nM	100000.0	CHEMBL2598	Homo sapiens	IC50	nM	100000.0
	2187200	CHEMBL966813	Inhibition of human PKCiota	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	364.0	CHEMBL2598	Homo sapiens	IC50	nM	364.0
	2251064	CHEMBL1011939	Inhibition of PKCiota at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	34.0	CHEMBL2598	Homo sapiens	INH	%	34.0
	2486603	CHEMBL994970	Inhibition of PKCiota	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	8330.0	CHEMBL2598	Homo sapiens	Ki	uM	8.33
	2721747	CHEMBL1053591	Inhibition of PKCiota at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	3052450	CHEMBL1070485	Residual activity of PKCiota at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL2598	Homo sapiens	Residual activity	%	87.0
	3052702	CHEMBL1040279	Residual activity of PKCiota at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	102.0	CHEMBL2598	Homo sapiens	Residual activity	%	102.0
	3054011	CHEMBL1050342	Residual activity of PKCiota at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	46.0	CHEMBL2598	Homo sapiens	Residual activity	%	46.0
	3054263	CHEMBL1070485	Residual activity of PKCiota at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	105.0	CHEMBL2598	Homo sapiens	Residual activity	%	105.0
	3055550	CHEMBL1040279	Residual activity of PKCiota at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	116.0	CHEMBL2598	Homo sapiens	Residual activity	%	116.0
	3056855	CHEMBL1050342	Residual activity of PKCiota at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	44.0	CHEMBL2598	Homo sapiens	Residual activity	%	44.0
	3057107	CHEMBL1070485	Residual activity of PKCiota at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL2598	Homo sapiens	Residual activity	%	102.0
	3058427	CHEMBL1040279	Residual activity of PKCiota at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	103.0	CHEMBL2598	Homo sapiens	Residual activity	%	103.0
	3059711	CHEMBL1050342	Residual activity of PKCiota at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	51.0	CHEMBL2598	Homo sapiens	Residual activity	%	51.0
	3214020	CHEMBL1103215	Inhibition of PKCiota at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL2598	Homo sapiens	INH	%	2.0
	3219696	CHEMBL1110447	Inhibition of PKCiota at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	24.0	CHEMBL2598	Homo sapiens	INH	%	24.0
	3224933	CHEMBL1101011	Inhibition of PKCiota at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	3226312	CHEMBL1101011	Inhibition of PKCiota at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	3358767	CHEMBL1175233	Inhibition of PRKCI at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	42.0	CHEMBL2598	Homo sapiens	INH	%	42.0
	3359209	CHEMBL1175233	Inhibition of PRKCI at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	40.0	CHEMBL2598	Homo sapiens	INH	%	40.0
	3443497	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	55.0	CHEMBL2598	Homo sapiens	INH	%	55.0
	3443714	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	25.0	CHEMBL2598	Homo sapiens	INH	%	25.0
	3444869	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL2598	Homo sapiens	INH	%	2.0
	3445493	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-4.0	CHEMBL2598	Homo sapiens	INH	%	-4.0
	3445710	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	17.0	CHEMBL2598	Homo sapiens	INH	%	17.0
	3445905	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	17.0	CHEMBL2598	Homo sapiens	INH	%	17.0
	3446095	CHEMBL1244263	Inhibition of PKCiota at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	7.0	CHEMBL2598	Homo sapiens	INH	%	7.0
	3463330	CHEMBL1251590	Inhibition of PRKCI at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	10.0	CHEMBL2598	Homo sapiens	INH	%	10.0
	3463874	CHEMBL1251590	Inhibition of PRKCI at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	13.0	CHEMBL2598	Homo sapiens	INH	%	13.0
	3464093	CHEMBL1251590	Inhibition of PRKCI at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	21.0	CHEMBL2598	Homo sapiens	INH	%	21.0
	3590777	CHEMBL1292146	Inhibition of human PKC-iota	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL2598	Homo sapiens	Ki	uM	1000.0
	5120301	CHEMBL1648684	Inhibition of human PKCiota at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	98.0	CHEMBL2598	Homo sapiens	INH	%	98.0
	5243753	CHEMBL1685857	Inhibition of PKCiota at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	109.0	CHEMBL2598	Homo sapiens	INH	%	109.0
	5243861	CHEMBL1686073	Inhibition of PKCiota at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	90.0	CHEMBL2598	Homo sapiens	INH	%	90.0
	5243974	CHEMBL1685857	Inhibition of PKCiota at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	89.0	CHEMBL2598	Homo sapiens	INH	%	89.0
	5244082	CHEMBL1686073	Inhibition of PKCiota at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	76.0	CHEMBL2598	Homo sapiens	INH	%	76.0
	5244955	CHEMBL1685857	Inhibition of PKCiota at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	94.0	CHEMBL2598	Homo sapiens	INH	%	94.0
	5245063	CHEMBL1686073	Inhibition of PKCiota at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	121.0	CHEMBL2598	Homo sapiens	INH	%	121.0
	5245214	CHEMBL1685857	Inhibition of PKCiota at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	125.0	CHEMBL2598	Homo sapiens	INH	%	125.0
	5246044	CHEMBL1686073	Inhibition of PKCiota at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	123.0	CHEMBL2598	Homo sapiens	INH	%	123.0
Not Active	6355783	CHEMBL1831994	Inhibition of PKCiota at 50 uM	B	CCCc1ccc(C(CC(=O)O)Cc2nc3cc(I)ccc3[nH]2)cc1		CHEMBL1829842		Inhibition	%		CHEMBL2598	Homo sapiens	INH		
Not Active	6355798	CHEMBL1831996	Inhibition of PKCiota at 200 uM	B	CCCc1ccc(C(CC(=O)O)Cc2nc3cc(I)ccc3[nH]2)cc1		CHEMBL1829842		Inhibition	%		CHEMBL2598	Homo sapiens	INH		
	7567278	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7567737	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7568208	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7568666	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7569251	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7569711	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7570204	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7570631	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7571227	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7571684	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7571718	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7572181	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7572597	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7573208	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7573699	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7574168	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7574576	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7575205	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7575676	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7576141	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7576549	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7576718	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7577177	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7577655	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7578125	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7578530	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7578726	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7579100	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7579550	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7580024	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7580493	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7580896	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7581084	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7581469	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7581914	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7582385	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7583430	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7583827	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7584272	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7584763	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7585167	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7585760	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7586168	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7586614	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7586643	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1400.0	CHEMBL2598	Homo sapiens	Kd	nM	1400.0
	7587097	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7587721	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7588140	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1800.0	CHEMBL2598	Homo sapiens	Kd	nM	1800.0
	7588622	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7589073	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7589686	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7590135	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7590609	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7591060	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7591639	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7592111	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	5800.0	CHEMBL2598	Homo sapiens	Kd	nM	5800.0
	7592584	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7593037	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7593184	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7593619	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7594091	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	250.0	CHEMBL2598	Homo sapiens	Kd	nM	250.0
	7594564	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7595016	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7595152	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7595596	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7596070	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7596541	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7596988	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	26.0	CHEMBL2598	Homo sapiens	Kd	nM	26.0
	7597124	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7597577	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7598050	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	7598520	CHEMBL1908580	Binding constant for PRKCI kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2598	Homo sapiens	Kd	nM	10000.0
	8061234	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.2	CHEMBL2598	Homo sapiens	Inhibition	%	-0.2
	8061411	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.54	CHEMBL2598	Homo sapiens	Inhibition	%	-0.54
	8061635	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.28	CHEMBL2598	Homo sapiens	Inhibition	%	0.28
	8061742	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.32	CHEMBL2598	Homo sapiens	Inhibition	%	1.32
	8061933	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.27	CHEMBL2598	Homo sapiens	Inhibition	%	0.27
	8062157	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.58	CHEMBL2598	Homo sapiens	Inhibition	%	1.58
	8062273	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.03	CHEMBL2598	Homo sapiens	Inhibition	%	1.03
	8062659	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.78	CHEMBL2598	Homo sapiens	Inhibition	%	2.78
	8062757	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.92	CHEMBL2598	Homo sapiens	Inhibition	%	1.92
	8062981	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.15	CHEMBL2598	Homo sapiens	Inhibition	%	-1.15
	8063113	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.02	CHEMBL2598	Homo sapiens	Inhibition	%	-0.02
	8063504	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-1.6	CHEMBL2598	Homo sapiens	Inhibition	%	-1.6
	8063612	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.81	CHEMBL2598	Homo sapiens	Inhibition	%	0.81
	8063836	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.05	CHEMBL2598	Homo sapiens	Inhibition	%	-0.05
	8064018	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-1.47	CHEMBL2598	Homo sapiens	Inhibition	%	-1.47
	8064133	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.76	CHEMBL2598	Homo sapiens	Inhibition	%	3.76
	8064357	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.04	CHEMBL2598	Homo sapiens	Inhibition	%	6.04
	8064567	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.0	CHEMBL2598	Homo sapiens	Inhibition	%	0.0
	8064705	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.08	CHEMBL2598	Homo sapiens	Inhibition	%	-0.08
	8064929	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.61	CHEMBL2598	Homo sapiens	Inhibition	%	0.61
	8065095	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.3	CHEMBL2598	Homo sapiens	Inhibition	%	0.3
	8065435	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.23	CHEMBL2598	Homo sapiens	Inhibition	%	1.23
	8065610	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.18	CHEMBL2598	Homo sapiens	Inhibition	%	2.18
	8065949	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	44.97	CHEMBL2598	Homo sapiens	Inhibition	%	44.97
	8066159	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.45	CHEMBL2598	Homo sapiens	Inhibition	%	-0.45
	8066519	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	-0.04	CHEMBL2598	Homo sapiens	Inhibition	%	-0.04
	8066685	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.23	CHEMBL2598	Homo sapiens	Inhibition	%	-0.23
	8067033	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.06	CHEMBL2598	Homo sapiens	Inhibition	%	0.06
	8067208	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.65	CHEMBL2598	Homo sapiens	Inhibition	%	0.65
	8067553	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.48	CHEMBL2598	Homo sapiens	Inhibition	%	0.48
	8067763	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.45	CHEMBL2598	Homo sapiens	Inhibition	%	1.45
	8068122	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.62	CHEMBL2598	Homo sapiens	Inhibition	%	0.62
	8068286	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.25	CHEMBL2598	Homo sapiens	Inhibition	%	0.25
	8068510	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.06	CHEMBL2598	Homo sapiens	Inhibition	%	0.06
	8068635	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.52	CHEMBL2598	Homo sapiens	Inhibition	%	-0.52
	8068809	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.49	CHEMBL2598	Homo sapiens	Inhibition	%	1.49
	8069033	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.48	CHEMBL2598	Homo sapiens	Inhibition	%	0.48
	8069158	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.99	CHEMBL2598	Homo sapiens	Inhibition	%	3.99
	8069453	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.6	CHEMBL2598	Homo sapiens	Inhibition	%	0.6
	8069838	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.57	CHEMBL2598	Homo sapiens	Inhibition	%	0.57
	8069964	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.26	CHEMBL2598	Homo sapiens	Inhibition	%	-1.26
	8070360	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.02	CHEMBL2598	Homo sapiens	Inhibition	%	2.02
	8070485	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.37	CHEMBL2598	Homo sapiens	Inhibition	%	-0.37
	8070709	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.12	CHEMBL2598	Homo sapiens	Inhibition	%	1.12
	8070783	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.12	CHEMBL2598	Homo sapiens	Inhibition	%	2.12
	8071164	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.13	CHEMBL2598	Homo sapiens	Inhibition	%	0.13
	8071290	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.4	CHEMBL2598	Homo sapiens	Inhibition	%	0.4
	8071514	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-1.7	CHEMBL2598	Homo sapiens	Inhibition	%	-1.7
	8071687	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.86	CHEMBL2598	Homo sapiens	Inhibition	%	0.86
	8072036	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.25	CHEMBL2598	Homo sapiens	Inhibition	%	-0.25
	8072126	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.71	CHEMBL2598	Homo sapiens	Inhibition	%	-0.71
	8072350	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.55	CHEMBL2598	Homo sapiens	Inhibition	%	-0.55
	8072507	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.48	CHEMBL2598	Homo sapiens	Inhibition	%	-0.48
	8072856	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.68	CHEMBL2598	Homo sapiens	Inhibition	%	-0.68
	8073023	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.37	CHEMBL2598	Homo sapiens	Inhibition	%	2.37
	8073372	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.66	CHEMBL2598	Homo sapiens	Inhibition	%	0.66
	8073491	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.59	CHEMBL2598	Homo sapiens	Inhibition	%	-1.59
	8073715	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.19	CHEMBL2598	Homo sapiens	Inhibition	%	0.19
	8073948	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.19	CHEMBL2598	Homo sapiens	Inhibition	%	0.19
	8074100	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.69	CHEMBL2598	Homo sapiens	Inhibition	%	-0.69
	8074454	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-2.2	CHEMBL2598	Homo sapiens	Inhibition	%	-2.2
	8074611	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.0	CHEMBL2598	Homo sapiens	Inhibition	%	0.0
	8074835	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.16	CHEMBL2598	Homo sapiens	Inhibition	%	0.16
	8074962	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.08	CHEMBL2598	Homo sapiens	Inhibition	%	-0.08
	8075297	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.16	CHEMBL2598	Homo sapiens	Inhibition	%	0.16
	8075534	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.41	CHEMBL2598	Homo sapiens	Inhibition	%	1.41
	8075675	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.11	CHEMBL2598	Homo sapiens	Inhibition	%	0.11
	8075899	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.87	CHEMBL2598	Homo sapiens	Inhibition	%	0.87
	8076041	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.03	CHEMBL2598	Homo sapiens	Inhibition	%	-1.03
	8076413	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.14	CHEMBL2598	Homo sapiens	Inhibition	%	1.14
	8076547	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.58	CHEMBL2598	Homo sapiens	Inhibition	%	0.58
	8076873	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.41	CHEMBL2598	Homo sapiens	Inhibition	%	0.41
	8077120	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.68	CHEMBL2598	Homo sapiens	Inhibition	%	3.68
	8077472	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.73	CHEMBL2598	Homo sapiens	Inhibition	%	-0.73
	8077623	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.45	CHEMBL2598	Homo sapiens	Inhibition	%	-0.45
	8077990	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.71	CHEMBL2598	Homo sapiens	Inhibition	%	1.71
	8078129	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.61	CHEMBL2598	Homo sapiens	Inhibition	%	-0.61
	8078353	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.05	CHEMBL2598	Homo sapiens	Inhibition	%	0.05
	8078455	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.01	CHEMBL2598	Homo sapiens	Inhibition	%	-0.01
	8078705	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	26.39	CHEMBL2598	Homo sapiens	Inhibition	%	26.39
	8079045	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-1.05	CHEMBL2598	Homo sapiens	Inhibition	%	-1.05
	8079203	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.24	CHEMBL2598	Homo sapiens	Inhibition	%	-0.24
	8079427	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.09	CHEMBL2598	Homo sapiens	Inhibition	%	1.09
	8079569	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.01	CHEMBL2598	Homo sapiens	Inhibition	%	1.01
	8079932	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.78	CHEMBL2598	Homo sapiens	Inhibition	%	0.78
	8080037	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.71	CHEMBL2598	Homo sapiens	Inhibition	%	4.71
	8080261	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-1.41	CHEMBL2598	Homo sapiens	Inhibition	%	-1.41
	8080289	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.44	CHEMBL2598	Homo sapiens	Inhibition	%	-0.44
	8080513	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.73	CHEMBL2598	Homo sapiens	Inhibition	%	1.73
	8080628	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.61	CHEMBL2598	Homo sapiens	Inhibition	%	0.61
	8081016	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.01	CHEMBL2598	Homo sapiens	Inhibition	%	-1.01
	8081151	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.01	CHEMBL2598	Homo sapiens	Inhibition	%	1.01
	8081519	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.12	CHEMBL2598	Homo sapiens	Inhibition	%	1.12
	8081846	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.5	CHEMBL2598	Homo sapiens	Inhibition	%	0.5
	8082098	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.01	CHEMBL2598	Homo sapiens	Inhibition	%	-0.01
	8082211	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.95	CHEMBL2598	Homo sapiens	Inhibition	%	-0.95
	8082435	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.59	CHEMBL2598	Homo sapiens	Inhibition	%	0.59
	8082608	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.48	CHEMBL2598	Homo sapiens	Inhibition	%	0.48
	8082731	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.17	CHEMBL2598	Homo sapiens	Inhibition	%	2.17
	8082955	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.33	CHEMBL2598	Homo sapiens	Inhibition	%	2.33
	8083111	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.0	CHEMBL2598	Homo sapiens	Inhibition	%	2.0
	8083434	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.49	CHEMBL2598	Homo sapiens	Inhibition	%	0.49
	8083688	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.76	CHEMBL2598	Homo sapiens	Inhibition	%	4.76
	8084022	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.68	CHEMBL2598	Homo sapiens	Inhibition	%	0.68
	8084207	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	-0.86	CHEMBL2598	Homo sapiens	Inhibition	%	-0.86
	8084549	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.79	CHEMBL2598	Homo sapiens	Inhibition	%	0.79
	8084710	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.81	CHEMBL2598	Homo sapiens	Inhibition	%	1.81
	8085032	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.91	CHEMBL2598	Homo sapiens	Inhibition	%	0.91
	8085288	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.06	CHEMBL2598	Homo sapiens	Inhibition	%	-1.06
	8085620	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8085809	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.52	CHEMBL2598	Homo sapiens	Inhibition	%	1.52
	8086148	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.74	CHEMBL2598	Homo sapiens	Inhibition	%	1.74
	8086310	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.63	CHEMBL2598	Homo sapiens	Inhibition	%	3.63
	8086534	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.06	CHEMBL2598	Homo sapiens	Inhibition	%	8.06
	8086633	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.76	CHEMBL2598	Homo sapiens	Inhibition	%	0.76
	8087068	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.96	CHEMBL2598	Homo sapiens	Inhibition	%	0.96
	8087226	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.11	CHEMBL2598	Homo sapiens	Inhibition	%	0.11
	8087564	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.88	CHEMBL2598	Homo sapiens	Inhibition	%	3.88
	8087702	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.76	CHEMBL2598	Homo sapiens	Inhibition	%	1.76
	8087926	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.81	CHEMBL2598	Homo sapiens	Inhibition	%	0.81
	8088068	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.89	CHEMBL2598	Homo sapiens	Inhibition	%	0.89
	8088440	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.73	CHEMBL2598	Homo sapiens	Inhibition	%	1.73
	8088568	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.86	CHEMBL2598	Homo sapiens	Inhibition	%	3.86
	8088885	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.6	CHEMBL2598	Homo sapiens	Inhibition	%	6.6
	8089237	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.06	CHEMBL2598	Homo sapiens	Inhibition	%	1.06
	8089385	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.62	CHEMBL2598	Homo sapiens	Inhibition	%	0.62
	8089729	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.15	CHEMBL2598	Homo sapiens	Inhibition	%	0.15
	8089909	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.18	CHEMBL2598	Homo sapiens	Inhibition	%	-1.18
	8090133	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.32	CHEMBL2598	Homo sapiens	Inhibition	%	0.32
	8090298	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.02	CHEMBL2598	Homo sapiens	Inhibition	%	-1.02
	8090465	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.08	CHEMBL2598	Homo sapiens	Inhibition	%	-0.08
	8090828	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.52	CHEMBL2598	Homo sapiens	Inhibition	%	0.52
	8091033	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.61	CHEMBL2598	Homo sapiens	Inhibition	%	1.61
	8091394	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	0.1	CHEMBL2598	Homo sapiens	Inhibition	%	0.1
	8091549	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.41	CHEMBL2598	Homo sapiens	Inhibition	%	0.41
	8091773	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.72	CHEMBL2598	Homo sapiens	Inhibition	%	0.72
	8091889	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.75	CHEMBL2598	Homo sapiens	Inhibition	%	3.75
	8092250	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.84	CHEMBL2598	Homo sapiens	Inhibition	%	1.84
	8092401	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.33	CHEMBL2598	Homo sapiens	Inhibition	%	1.33
	8092773	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.71	CHEMBL2598	Homo sapiens	Inhibition	%	0.71
	8092902	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.88	CHEMBL2598	Homo sapiens	Inhibition	%	4.88
	8093126	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.03	CHEMBL2598	Homo sapiens	Inhibition	%	4.03
	8093214	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.77	CHEMBL2598	Homo sapiens	Inhibition	%	0.77
	8093578	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.26	CHEMBL2598	Homo sapiens	Inhibition	%	1.26
	8093717	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.09	CHEMBL2598	Homo sapiens	Inhibition	%	0.09
	8093941	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.47	CHEMBL2598	Homo sapiens	Inhibition	%	0.47
	8094061	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.52	CHEMBL2598	Homo sapiens	Inhibition	%	-1.52
	8094465	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.83	CHEMBL2598	Homo sapiens	Inhibition	%	-0.83
	8094640	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-0.5	CHEMBL2598	Homo sapiens	Inhibition	%	-0.5
	8094796	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-1.15	CHEMBL2598	Homo sapiens	Inhibition	%	-1.15
	8095020	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.33	CHEMBL2598	Homo sapiens	Inhibition	%	1.33
	8095160	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.73	CHEMBL2598	Homo sapiens	Inhibition	%	-0.73
	8095363	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.87	CHEMBL2598	Homo sapiens	Inhibition	%	1.87
	8095587	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.18	CHEMBL2598	Homo sapiens	Inhibition	%	0.18
	8095728	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.27	CHEMBL2598	Homo sapiens	Inhibition	%	1.27
	8096100	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.48	CHEMBL2598	Homo sapiens	Inhibition	%	0.48
	8096217	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.13	CHEMBL2598	Homo sapiens	Inhibition	%	4.13
	8096580	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.72	CHEMBL2598	Homo sapiens	Inhibition	%	1.72
	8096736	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8096960	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.36	CHEMBL2598	Homo sapiens	Inhibition	%	0.36
	8097107	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8097414	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.1	CHEMBL2598	Homo sapiens	Inhibition	%	4.1
	8097638	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.1	CHEMBL2598	Homo sapiens	Inhibition	%	4.1
	8097788	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.8	CHEMBL2598	Homo sapiens	Inhibition	%	0.8
	8098145	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.28	CHEMBL2598	Homo sapiens	Inhibition	%	-1.28
	8098265	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.74	CHEMBL2598	Homo sapiens	Inhibition	%	-0.74
	8098489	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.85	CHEMBL2598	Homo sapiens	Inhibition	%	-0.85
	8098669	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-1.29	CHEMBL2598	Homo sapiens	Inhibition	%	-1.29
	8098854	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.42	CHEMBL2598	Homo sapiens	Inhibition	%	0.42
	8099222	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.97	CHEMBL2598	Homo sapiens	Inhibition	%	0.97
	8099364	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.95	CHEMBL2598	Homo sapiens	Inhibition	%	0.95
	8099782	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.6	CHEMBL2598	Homo sapiens	Inhibition	%	0.6
	8099929	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.65	CHEMBL2598	Homo sapiens	Inhibition	%	1.65
	8100299	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.0	CHEMBL2598	Homo sapiens	Inhibition	%	1.0
	8100415	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.51	CHEMBL2598	Homo sapiens	Inhibition	%	3.51
	8100639	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.09	CHEMBL2598	Homo sapiens	Inhibition	%	2.09
	8100779	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.88	CHEMBL2598	Homo sapiens	Inhibition	%	1.88
	8101163	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.27	CHEMBL2598	Homo sapiens	Inhibition	%	1.27
	8101305	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.32	CHEMBL2598	Homo sapiens	Inhibition	%	0.32
	8101714	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.88	CHEMBL2598	Homo sapiens	Inhibition	%	3.88
	8101967	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	20.31	CHEMBL2598	Homo sapiens	Inhibition	%	20.31
	8102122	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.89	CHEMBL2598	Homo sapiens	Inhibition	%	-0.89
	8102477	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8102821	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.3	CHEMBL2598	Homo sapiens	Inhibition	%	-0.3
	8102999	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.86	CHEMBL2598	Homo sapiens	Inhibition	%	-0.86
	8103195	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.16	CHEMBL2598	Homo sapiens	Inhibition	%	0.16
	8103419	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.1	CHEMBL2598	Homo sapiens	Inhibition	%	3.1
	8103557	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.38	CHEMBL2598	Homo sapiens	Inhibition	%	-0.38
	8103707	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.41	CHEMBL2598	Homo sapiens	Inhibition	%	1.41
	8103931	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.37	CHEMBL2598	Homo sapiens	Inhibition	%	1.37
	8104116	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.42	CHEMBL2598	Homo sapiens	Inhibition	%	0.42
	8104264	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.86	CHEMBL2598	Homo sapiens	Inhibition	%	1.86
	8104488	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.84	CHEMBL2598	Homo sapiens	Inhibition	%	1.84
	8104634	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.97	CHEMBL2598	Homo sapiens	Inhibition	%	0.97
	8104972	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.63	CHEMBL2598	Homo sapiens	Inhibition	%	2.63
	8105112	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.87	CHEMBL2598	Homo sapiens	Inhibition	%	1.87
	8105336	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.94	CHEMBL2598	Homo sapiens	Inhibition	%	1.94
	8105502	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.12	CHEMBL2598	Homo sapiens	Inhibition	%	1.12
	8105640	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.77	CHEMBL2598	Homo sapiens	Inhibition	%	0.77
	8105864	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.88	CHEMBL2598	Homo sapiens	Inhibition	%	2.88
	8105920	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.27	CHEMBL2598	Homo sapiens	Inhibition	%	0.27
	8106144	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.04	CHEMBL2598	Homo sapiens	Inhibition	%	2.04
	8106309	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.91	CHEMBL2598	Homo sapiens	Inhibition	%	0.91
	8106465	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.43	CHEMBL2598	Homo sapiens	Inhibition	%	-1.43
	8106689	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.51	CHEMBL2598	Homo sapiens	Inhibition	%	2.51
	8106818	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.91	CHEMBL2598	Homo sapiens	Inhibition	%	-0.91
	8107163	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.28	CHEMBL2598	Homo sapiens	Inhibition	%	0.28
	8107335	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.97	CHEMBL2598	Homo sapiens	Inhibition	%	0.97
	8107760	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.43	CHEMBL2598	Homo sapiens	Inhibition	%	1.43
	8107895	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.03	CHEMBL2598	Homo sapiens	Inhibition	%	-1.03
	8108277	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.74	CHEMBL2598	Homo sapiens	Inhibition	%	0.74
	8108452	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.23	CHEMBL2598	Homo sapiens	Inhibition	%	0.23
	8108823	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.7	CHEMBL2598	Homo sapiens	Inhibition	%	2.7
	8108965	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.8	CHEMBL2598	Homo sapiens	Inhibition	%	0.8
	8109303	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.05	CHEMBL2598	Homo sapiens	Inhibition	%	3.05
	8109657	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.01	CHEMBL2598	Homo sapiens	Inhibition	%	-0.01
	8109828	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.89	CHEMBL2598	Homo sapiens	Inhibition	%	2.89
	8110184	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.11	CHEMBL2598	Homo sapiens	Inhibition	%	3.11
	8110463	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.11	CHEMBL2598	Homo sapiens	Inhibition	%	0.11
	8110629	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.26	CHEMBL2598	Homo sapiens	Inhibition	%	2.26
	8111011	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	16.52	CHEMBL2598	Homo sapiens	Inhibition	%	16.52
	8111134	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.46	CHEMBL2598	Homo sapiens	Inhibition	%	0.46
	8111358	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-1.58	CHEMBL2598	Homo sapiens	Inhibition	%	-1.58
	8111485	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.62	CHEMBL2598	Homo sapiens	Inhibition	%	0.62
	8111651	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8111875	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.53	CHEMBL2598	Homo sapiens	Inhibition	%	-0.53
	8112080	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.2	CHEMBL2598	Homo sapiens	Inhibition	%	2.2
	8112217	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.18	CHEMBL2598	Homo sapiens	Inhibition	%	-1.18
	8112441	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.8	CHEMBL2598	Homo sapiens	Inhibition	%	-0.8
	8112609	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.76	CHEMBL2598	Homo sapiens	Inhibition	%	1.76
	8112781	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.27	CHEMBL2598	Homo sapiens	Inhibition	%	0.27
	8113005	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.03	CHEMBL2598	Homo sapiens	Inhibition	%	-1.03
	8113157	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.89	CHEMBL2598	Homo sapiens	Inhibition	%	0.89
	8113293	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.31	CHEMBL2598	Homo sapiens	Inhibition	%	0.31
	8113517	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.76	CHEMBL2598	Homo sapiens	Inhibition	%	0.76
	8113641	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.72	CHEMBL2598	Homo sapiens	Inhibition	%	2.72
	8113981	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.33	CHEMBL2598	Homo sapiens	Inhibition	%	0.33
	8114157	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.37	CHEMBL2598	Homo sapiens	Inhibition	%	2.37
	8114513	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.45	CHEMBL2598	Homo sapiens	Inhibition	%	2.45
	8114789	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.97	CHEMBL2598	Homo sapiens	Inhibition	%	2.97
	8114955	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.22	CHEMBL2598	Homo sapiens	Inhibition	%	1.22
	8115179	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.9	CHEMBL2598	Homo sapiens	Inhibition	%	2.9
	8115344	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.57	CHEMBL2598	Homo sapiens	Inhibition	%	0.57
	8115688	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.92	CHEMBL2598	Homo sapiens	Inhibition	%	-0.92
	8115821	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	11.39	CHEMBL2598	Homo sapiens	Inhibition	%	11.39
	8116204	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.82	CHEMBL2598	Homo sapiens	Inhibition	%	-0.82
	8116407	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-0.03	CHEMBL2598	Homo sapiens	Inhibition	%	-0.03
	8116765	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.39	CHEMBL2598	Homo sapiens	Inhibition	%	-1.39
	8116937	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.27	CHEMBL2598	Homo sapiens	Inhibition	%	2.27
	8117332	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.18	CHEMBL2598	Homo sapiens	Inhibition	%	0.18
	8117490	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.21	CHEMBL2598	Homo sapiens	Inhibition	%	1.21
	8117844	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.11	CHEMBL2598	Homo sapiens	Inhibition	%	1.11
	8117982	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.82	CHEMBL2598	Homo sapiens	Inhibition	%	1.82
	8118206	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.79	CHEMBL2598	Homo sapiens	Inhibition	%	1.79
	8118322	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.0	CHEMBL2598	Homo sapiens	Inhibition	%	1.0
	8118494	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.7	CHEMBL2598	Homo sapiens	Inhibition	%	2.7
	8118718	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.67	CHEMBL2598	Homo sapiens	Inhibition	%	2.67
	8118854	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.35	CHEMBL2598	Homo sapiens	Inhibition	%	2.35
	8119125	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.31	CHEMBL2598	Homo sapiens	Inhibition	%	-0.31
	8119508	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.32	CHEMBL2598	Homo sapiens	Inhibition	%	1.32
	8119675	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.05	CHEMBL2598	Homo sapiens	Inhibition	%	-0.05
	8120018	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.18	CHEMBL2598	Homo sapiens	Inhibition	%	-0.18
	8120157	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.29	CHEMBL2598	Homo sapiens	Inhibition	%	0.29
	8120381	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.15	CHEMBL2598	Homo sapiens	Inhibition	%	1.15
	8120541	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.84	CHEMBL2598	Homo sapiens	Inhibition	%	-1.84
	8120742	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	6.53	CHEMBL2598	Homo sapiens	Inhibition	%	6.53
	8121094	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-2.44	CHEMBL2598	Homo sapiens	Inhibition	%	-2.44
	8121266	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.08	CHEMBL2598	Homo sapiens	Inhibition	%	2.08
	8121490	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.38	CHEMBL2598	Homo sapiens	Inhibition	%	2.38
	8121657	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.06	CHEMBL2598	Homo sapiens	Inhibition	%	1.06
	8121820	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.56	CHEMBL2598	Homo sapiens	Inhibition	%	1.56
	8122165	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.26	CHEMBL2598	Homo sapiens	Inhibition	%	0.26
	8122527	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.93	CHEMBL2598	Homo sapiens	Inhibition	%	1.93
	8122647	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.99	CHEMBL2598	Homo sapiens	Inhibition	%	0.99
	8123038	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.89	CHEMBL2598	Homo sapiens	Inhibition	%	2.89
	8123180	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.36	CHEMBL2598	Homo sapiens	Inhibition	%	3.36
	8123404	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.32	CHEMBL2598	Homo sapiens	Inhibition	%	3.32
	8123458	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.29	CHEMBL2598	Homo sapiens	Inhibition	%	1.29
	8123832	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.26	CHEMBL2598	Homo sapiens	Inhibition	%	5.26
	8123999	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.58	CHEMBL2598	Homo sapiens	Inhibition	%	0.58
	8124223	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.97	CHEMBL2598	Homo sapiens	Inhibition	%	-0.97
	8124342	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.42	CHEMBL2598	Homo sapiens	Inhibition	%	-1.42
	8124705	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.11	CHEMBL2598	Homo sapiens	Inhibition	%	-0.11
	8124870	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.97	CHEMBL2598	Homo sapiens	Inhibition	%	-0.97
	8125071	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.16	CHEMBL2598	Homo sapiens	Inhibition	%	0.16
	8125295	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.79	CHEMBL2598	Homo sapiens	Inhibition	%	1.79
	8125425	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.5	CHEMBL2598	Homo sapiens	Inhibition	%	-0.5
	8125817	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.84	CHEMBL2598	Homo sapiens	Inhibition	%	1.84
	8125981	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.71	CHEMBL2598	Homo sapiens	Inhibition	%	-0.71
	8126145	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-0.46	CHEMBL2598	Homo sapiens	Inhibition	%	-0.46
	8126369	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.27	CHEMBL2598	Homo sapiens	Inhibition	%	1.27
	8126484	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.4	CHEMBL2598	Homo sapiens	Inhibition	%	0.4
	8126844	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.78	CHEMBL2598	Homo sapiens	Inhibition	%	2.78
	8126966	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.22	CHEMBL2598	Homo sapiens	Inhibition	%	1.22
	8127190	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.19	CHEMBL2598	Homo sapiens	Inhibition	%	2.19
	8127357	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.05	CHEMBL2598	Homo sapiens	Inhibition	%	2.05
	8127723	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.47	CHEMBL2598	Homo sapiens	Inhibition	%	3.47
	8127787	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.93	CHEMBL2598	Homo sapiens	Inhibition	%	0.93
	8128011	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.81	CHEMBL2598	Homo sapiens	Inhibition	%	1.81
	8128163	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.51	CHEMBL2598	Homo sapiens	Inhibition	%	0.51
	8128554	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.77	CHEMBL2598	Homo sapiens	Inhibition	%	1.77
	8128673	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.07	CHEMBL2598	Homo sapiens	Inhibition	%	-1.07
	8129034	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.31	CHEMBL2598	Homo sapiens	Inhibition	%	-1.31
	8129205	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.87	CHEMBL2598	Homo sapiens	Inhibition	%	-1.87
	8129429	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.84	CHEMBL2598	Homo sapiens	Inhibition	%	-1.84
	8129618	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.67	CHEMBL2598	Homo sapiens	Inhibition	%	-0.67
	8129757	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.56	CHEMBL2598	Homo sapiens	Inhibition	%	-0.56
	8130142	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8130314	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.05	CHEMBL2598	Homo sapiens	Inhibition	%	-1.05
	8130698	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.03	CHEMBL2598	Homo sapiens	Inhibition	%	2.03
	8130814	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.14	CHEMBL2598	Homo sapiens	Inhibition	%	2.14
	8131038	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.77	CHEMBL2598	Homo sapiens	Inhibition	%	1.77
	8131177	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.32	CHEMBL2598	Homo sapiens	Inhibition	%	3.32
	8131521	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.16	CHEMBL2598	Homo sapiens	Inhibition	%	1.16
	8131688	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.04	CHEMBL2598	Homo sapiens	Inhibition	%	3.04
	8132053	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.34	CHEMBL2598	Homo sapiens	Inhibition	%	3.34
	8132339	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.9	CHEMBL2598	Homo sapiens	Inhibition	%	0.9
	8132486	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.32	CHEMBL2598	Homo sapiens	Inhibition	%	1.32
	8132710	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.23	CHEMBL2598	Homo sapiens	Inhibition	%	0.23
	8132878	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.56	CHEMBL2598	Homo sapiens	Inhibition	%	0.56
	8132999	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.38	CHEMBL2598	Homo sapiens	Inhibition	%	-0.38
	8133223	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-1.34	CHEMBL2598	Homo sapiens	Inhibition	%	-1.34
	8133361	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8133757	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.48	CHEMBL2598	Homo sapiens	Inhibition	%	-1.48
	8133937	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.1	CHEMBL2598	Homo sapiens	Inhibition	%	-0.1
	8134085	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.83	CHEMBL2598	Homo sapiens	Inhibition	%	-0.83
	8134309	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.03	CHEMBL2598	Homo sapiens	Inhibition	%	-1.03
	8134469	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8134653	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.38	CHEMBL2598	Homo sapiens	Inhibition	%	-1.38
	8134877	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.98	CHEMBL2598	Homo sapiens	Inhibition	%	-0.98
	8135037	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.86	CHEMBL2598	Homo sapiens	Inhibition	%	0.86
	8135376	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.93	CHEMBL2598	Homo sapiens	Inhibition	%	1.93
	8135517	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.07	CHEMBL2598	Homo sapiens	Inhibition	%	3.07
	8135862	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8136030	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.63	CHEMBL2598	Homo sapiens	Inhibition	%	1.63
	8136254	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.72	CHEMBL2598	Homo sapiens	Inhibition	%	1.72
	8136398	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.45	CHEMBL2598	Homo sapiens	Inhibition	%	4.45
	8136688	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.43	CHEMBL2598	Homo sapiens	Inhibition	%	1.43
	8137047	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.03	CHEMBL2598	Homo sapiens	Inhibition	%	-0.03
	8137210	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.86	CHEMBL2598	Homo sapiens	Inhibition	%	3.86
	8137554	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.41	CHEMBL2598	Homo sapiens	Inhibition	%	-1.41
	8137702	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.36	CHEMBL2598	Homo sapiens	Inhibition	%	1.36
	8138092	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.75	CHEMBL2598	Homo sapiens	Inhibition	%	-0.75
	8138271	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.91	CHEMBL2598	Homo sapiens	Inhibition	%	-0.91
	8138643	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.44	CHEMBL2598	Homo sapiens	Inhibition	%	-0.44
	8138801	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.02	CHEMBL2598	Homo sapiens	Inhibition	%	-0.02
	8139210	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.72	CHEMBL2598	Homo sapiens	Inhibition	%	0.72
	8139369	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.38	CHEMBL2598	Homo sapiens	Inhibition	%	1.38
	8139707	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.76	CHEMBL2598	Homo sapiens	Inhibition	%	2.76
	8139848	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.42	CHEMBL2598	Homo sapiens	Inhibition	%	3.42
	8140072	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.26	CHEMBL2598	Homo sapiens	Inhibition	%	2.26
	8140195	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8140578	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.11	CHEMBL2598	Homo sapiens	Inhibition	%	1.11
	8140721	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.29	CHEMBL2598	Homo sapiens	Inhibition	%	4.29
	8141023	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.44	CHEMBL2598	Homo sapiens	Inhibition	%	1.44
	8141377	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.28	CHEMBL2598	Homo sapiens	Inhibition	%	1.28
	8141537	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	12.49	CHEMBL2598	Homo sapiens	Inhibition	%	12.49
	8141880	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.56	CHEMBL2598	Homo sapiens	Inhibition	%	-1.56
	8142041	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.29	CHEMBL2598	Homo sapiens	Inhibition	%	-0.29
	8142265	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.67	CHEMBL2598	Homo sapiens	Inhibition	%	0.67
	8142433	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.38	CHEMBL2598	Homo sapiens	Inhibition	%	-1.38
	8142609	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.71	CHEMBL2598	Homo sapiens	Inhibition	%	-0.71
	8142833	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.08	CHEMBL2598	Homo sapiens	Inhibition	%	-0.08
	8142982	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.8	CHEMBL2598	Homo sapiens	Inhibition	%	-0.8
	8143137	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.82	CHEMBL2598	Homo sapiens	Inhibition	%	1.82
	8143361	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.53	CHEMBL2598	Homo sapiens	Inhibition	%	1.53
	8143548	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.75	CHEMBL2598	Homo sapiens	Inhibition	%	1.75
	8143707	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.34	CHEMBL2598	Homo sapiens	Inhibition	%	1.34
	8143931	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.37	CHEMBL2598	Homo sapiens	Inhibition	%	1.37
	8144045	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.91	CHEMBL2598	Homo sapiens	Inhibition	%	2.91
	8144408	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.41	CHEMBL2598	Homo sapiens	Inhibition	%	2.41
	8144538	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.01	CHEMBL2598	Homo sapiens	Inhibition	%	2.01
	8144762	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.53	CHEMBL2598	Homo sapiens	Inhibition	%	2.53
	8144915	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.04	CHEMBL2598	Homo sapiens	Inhibition	%	1.04
	8145052	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.15	CHEMBL2598	Homo sapiens	Inhibition	%	4.15
	8145276	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.31	CHEMBL2598	Homo sapiens	Inhibition	%	4.31
	8145365	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.35	CHEMBL2598	Homo sapiens	Inhibition	%	3.35
	8145589	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.28	CHEMBL2598	Homo sapiens	Inhibition	%	1.28
	8145713	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.15	CHEMBL2598	Homo sapiens	Inhibition	%	-0.15
	8145874	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.27	CHEMBL2598	Homo sapiens	Inhibition	%	1.27
	8146098	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.5	CHEMBL2598	Homo sapiens	Inhibition	%	1.5
	8146218	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.54	CHEMBL2598	Homo sapiens	Inhibition	%	-0.54
	8146602	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.4	CHEMBL2598	Homo sapiens	Inhibition	%	-0.4
	8146769	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.4	CHEMBL2598	Homo sapiens	Inhibition	%	0.4
	8147162	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.91	CHEMBL2598	Homo sapiens	Inhibition	%	5.91
	8147304	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.68	CHEMBL2598	Homo sapiens	Inhibition	%	0.68
	8147681	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.94	CHEMBL2598	Homo sapiens	Inhibition	%	0.94
	8147868	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.17	CHEMBL2598	Homo sapiens	Inhibition	%	1.17
	8148250	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.64	CHEMBL2598	Homo sapiens	Inhibition	%	1.64
	8148364	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.72	CHEMBL2598	Homo sapiens	Inhibition	%	2.72
	8148588	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.77	CHEMBL2598	Homo sapiens	Inhibition	%	2.77
	8148727	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.2	CHEMBL2598	Homo sapiens	Inhibition	%	2.2
	8149089	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.91	CHEMBL2598	Homo sapiens	Inhibition	%	1.91
	8149248	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8149606	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	9.63	CHEMBL2598	Homo sapiens	Inhibition	%	9.63
	8149928	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.8	CHEMBL2598	Homo sapiens	Inhibition	%	3.8
	8150053	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.86	CHEMBL2598	Homo sapiens	Inhibition	%	0.86
	8150437	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.26	CHEMBL2598	Homo sapiens	Inhibition	%	0.26
	8150557	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.22	CHEMBL2598	Homo sapiens	Inhibition	%	0.22
	8150781	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.5	CHEMBL2598	Homo sapiens	Inhibition	%	-0.5
	8150946	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.5	CHEMBL2598	Homo sapiens	Inhibition	%	-0.5
	8151109	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.83	CHEMBL2598	Homo sapiens	Inhibition	%	-1.83
	8151333	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.13	CHEMBL2598	Homo sapiens	Inhibition	%	-1.13
	8151510	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.47	CHEMBL2598	Homo sapiens	Inhibition	%	0.47
	8151648	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.06	CHEMBL2598	Homo sapiens	Inhibition	%	0.06
	8151872	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.45	CHEMBL2598	Homo sapiens	Inhibition	%	1.45
	8152026	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.08	CHEMBL2598	Homo sapiens	Inhibition	%	-0.08
	8152214	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.96	CHEMBL2598	Homo sapiens	Inhibition	%	0.96
	8152438	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.96	CHEMBL2598	Homo sapiens	Inhibition	%	0.96
	8152596	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.9	CHEMBL2598	Homo sapiens	Inhibition	%	0.9
	8152934	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.66	CHEMBL2598	Homo sapiens	Inhibition	%	2.66
	8153073	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.42	CHEMBL2598	Homo sapiens	Inhibition	%	1.42
	8153434	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.74	CHEMBL2598	Homo sapiens	Inhibition	%	1.74
	8153591	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.81	CHEMBL2598	Homo sapiens	Inhibition	%	0.81
	8153815	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.17	CHEMBL2598	Homo sapiens	Inhibition	%	1.17
	8153948	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	39.96	CHEMBL2598	Homo sapiens	Inhibition	%	39.96
	8154269	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.65	CHEMBL2598	Homo sapiens	Inhibition	%	1.65
	8154395	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.83	CHEMBL2598	Homo sapiens	Inhibition	%	-0.83
	8154619	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.04	CHEMBL2598	Homo sapiens	Inhibition	%	1.04
	8154778	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.26	CHEMBL2598	Homo sapiens	Inhibition	%	-0.26
	8155122	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.08	CHEMBL2598	Homo sapiens	Inhibition	%	0.08
	8155298	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.75	CHEMBL2598	Homo sapiens	Inhibition	%	-0.75
	8155683	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.63	CHEMBL2598	Homo sapiens	Inhibition	%	-0.63
	8155861	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.64	CHEMBL2598	Homo sapiens	Inhibition	%	0.64
	8156223	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.72	CHEMBL2598	Homo sapiens	Inhibition	%	0.72
	8156435	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.54	CHEMBL2598	Homo sapiens	Inhibition	%	2.54
	8156585	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-0.79	CHEMBL2598	Homo sapiens	Inhibition	%	-0.79
	8156809	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.77	CHEMBL2598	Homo sapiens	Inhibition	%	2.77
	8156952	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.3	CHEMBL2598	Homo sapiens	Inhibition	%	1.3
	8157296	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.85	CHEMBL2598	Homo sapiens	Inhibition	%	2.85
	8157437	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.74	CHEMBL2598	Homo sapiens	Inhibition	%	0.74
	8157661	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.54	CHEMBL2598	Homo sapiens	Inhibition	%	0.54
	8157791	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.03	CHEMBL2598	Homo sapiens	Inhibition	%	1.03
	8157952	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.56	CHEMBL2598	Homo sapiens	Inhibition	%	2.56
	8158176	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.14	CHEMBL2598	Homo sapiens	Inhibition	%	1.14
	8158426	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.94	CHEMBL2598	Homo sapiens	Inhibition	%	8.94
	8158584	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.68	CHEMBL2598	Homo sapiens	Inhibition	%	3.68
	8158977	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.69	CHEMBL2598	Homo sapiens	Inhibition	%	2.69
	8159112	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.77	CHEMBL2598	Homo sapiens	Inhibition	%	1.77
	8159456	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.39	CHEMBL2598	Homo sapiens	Inhibition	%	1.39
	8159811	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	0.84	CHEMBL2598	Homo sapiens	Inhibition	%	0.84
	8159952	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.9	CHEMBL2598	Homo sapiens	Inhibition	%	3.9
	8160313	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.6	CHEMBL2598	Homo sapiens	Inhibition	%	0.6
	8160463	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.25	CHEMBL2598	Homo sapiens	Inhibition	%	1.25
	8160757	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.8	CHEMBL2598	Homo sapiens	Inhibition	%	2.8
	8161131	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.1	CHEMBL2598	Homo sapiens	Inhibition	%	2.1
	8161274	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.88	CHEMBL2598	Homo sapiens	Inhibition	%	2.88
	8161498	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.82	CHEMBL2598	Homo sapiens	Inhibition	%	1.82
	8161623	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.73	CHEMBL2598	Homo sapiens	Inhibition	%	1.73
	8161985	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8162115	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.39	CHEMBL2598	Homo sapiens	Inhibition	%	0.39
	8162499	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.05	CHEMBL2598	Homo sapiens	Inhibition	%	1.05
	8162752	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	39.95	CHEMBL2598	Homo sapiens	Inhibition	%	39.95
	8162900	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.56	CHEMBL2598	Homo sapiens	Inhibition	%	2.56
	8163124	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.28	CHEMBL2598	Homo sapiens	Inhibition	%	5.28
	8163293	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.98	CHEMBL2598	Homo sapiens	Inhibition	%	1.98
	8163427	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.9	CHEMBL2598	Homo sapiens	Inhibition	%	0.9
	8163651	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.23	CHEMBL2598	Homo sapiens	Inhibition	%	2.23
	8163774	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.01	CHEMBL2598	Homo sapiens	Inhibition	%	1.01
	8164132	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.93	CHEMBL2598	Homo sapiens	Inhibition	%	2.93
	8164272	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.48	CHEMBL2598	Homo sapiens	Inhibition	%	0.48
	8164496	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.2	CHEMBL2598	Homo sapiens	Inhibition	%	0.2
	8164651	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	0.78	CHEMBL2598	Homo sapiens	Inhibition	%	0.78
	8164795	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.01	CHEMBL2598	Homo sapiens	Inhibition	%	0.01
	8165019	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.75	CHEMBL2598	Homo sapiens	Inhibition	%	0.75
	8165089	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.89	CHEMBL2598	Homo sapiens	Inhibition	%	1.89
	8165313	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.01	CHEMBL2598	Homo sapiens	Inhibition	%	2.01
	8165454	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.8	CHEMBL2598	Homo sapiens	Inhibition	%	2.8
	8165821	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.16	CHEMBL2598	Homo sapiens	Inhibition	%	0.16
	8165947	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.13	CHEMBL2598	Homo sapiens	Inhibition	%	3.13
	8166309	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.46	CHEMBL2598	Homo sapiens	Inhibition	%	0.46
	8166439	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.08	CHEMBL2598	Homo sapiens	Inhibition	%	1.08
	8166663	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.18	CHEMBL2598	Homo sapiens	Inhibition	%	0.18
	8166764	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.92	CHEMBL2598	Homo sapiens	Inhibition	%	3.92
	8167076	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	23.39	CHEMBL2598	Homo sapiens	Inhibition	%	23.39
	8167441	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.68	CHEMBL2598	Homo sapiens	Inhibition	%	2.68
	8167605	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.38	CHEMBL2598	Homo sapiens	Inhibition	%	2.38
	8167962	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.51	CHEMBL2598	Homo sapiens	Inhibition	%	1.51
	8168086	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.83	CHEMBL2598	Homo sapiens	Inhibition	%	1.83
	8168310	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.22	CHEMBL2598	Homo sapiens	Inhibition	%	1.22
	8168451	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.98	CHEMBL2598	Homo sapiens	Inhibition	%	1.98
	8168811	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.3	CHEMBL2598	Homo sapiens	Inhibition	%	0.3
	8168975	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.84	CHEMBL2598	Homo sapiens	Inhibition	%	1.84
	8169341	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.13	CHEMBL2598	Homo sapiens	Inhibition	%	3.13
	8169645	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.26	CHEMBL2598	Homo sapiens	Inhibition	%	2.26
	8169779	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.09	CHEMBL2598	Homo sapiens	Inhibition	%	0.09
	8170148	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.82	CHEMBL2598	Homo sapiens	Inhibition	%	2.82
	8170273	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.18	CHEMBL2598	Homo sapiens	Inhibition	%	1.18
	8170497	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.53	CHEMBL2598	Homo sapiens	Inhibition	%	2.53
	8170637	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.7	CHEMBL2598	Homo sapiens	Inhibition	%	-0.7
	8170996	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.41	CHEMBL2598	Homo sapiens	Inhibition	%	0.41
	8171193	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.08	CHEMBL2598	Homo sapiens	Inhibition	%	1.08
	8171410	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	64.89	CHEMBL2598	Homo sapiens	Inhibition	%	64.89
	8171775	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.01	CHEMBL2598	Homo sapiens	Inhibition	%	5.01
	8171928	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.95	CHEMBL2598	Homo sapiens	Inhibition	%	1.95
	8172152	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.9	CHEMBL2598	Homo sapiens	Inhibition	%	1.9
	8172284	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.72	CHEMBL2598	Homo sapiens	Inhibition	%	1.72
	8172636	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.38	CHEMBL2598	Homo sapiens	Inhibition	%	0.38
	8172778	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.92	CHEMBL2598	Homo sapiens	Inhibition	%	3.92
	8173138	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.53	CHEMBL2598	Homo sapiens	Inhibition	%	0.53
	8173303	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.39	CHEMBL2598	Homo sapiens	Inhibition	%	3.39
	8173527	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	13.06	CHEMBL2598	Homo sapiens	Inhibition	%	13.06
	8173668	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.6	CHEMBL2598	Homo sapiens	Inhibition	%	1.6
	8173979	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.34	CHEMBL2598	Homo sapiens	Inhibition	%	2.34
	8174111	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.79	CHEMBL2598	Homo sapiens	Inhibition	%	2.79
	8174335	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.49	CHEMBL2598	Homo sapiens	Inhibition	%	0.49
	8174483	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.21	CHEMBL2598	Homo sapiens	Inhibition	%	2.21
	8174829	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.37	CHEMBL2598	Homo sapiens	Inhibition	%	1.37
	8174972	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	13.47	CHEMBL2598	Homo sapiens	Inhibition	%	13.47
	8175332	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.49	CHEMBL2598	Homo sapiens	Inhibition	%	-0.49
	8175588	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.15	CHEMBL2598	Homo sapiens	Inhibition	%	2.15
	8175751	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.3	CHEMBL2598	Homo sapiens	Inhibition	%	2.3
	8175975	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.87	CHEMBL2598	Homo sapiens	Inhibition	%	3.87
	8176128	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.36	CHEMBL2598	Homo sapiens	Inhibition	%	4.36
	8176501	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.24	CHEMBL2598	Homo sapiens	Inhibition	%	2.24
	8176633	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	0.7	CHEMBL2598	Homo sapiens	Inhibition	%	0.7
	8176987	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.37	CHEMBL2598	Homo sapiens	Inhibition	%	-0.37
	8177129	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.14	CHEMBL2598	Homo sapiens	Inhibition	%	2.14
	8177353	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.11	CHEMBL2598	Homo sapiens	Inhibition	%	2.11
	8177491	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.72	CHEMBL2598	Homo sapiens	Inhibition	%	0.72
	8177879	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.17	CHEMBL2598	Homo sapiens	Inhibition	%	2.17
	8178019	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.35	CHEMBL2598	Homo sapiens	Inhibition	%	3.35
	8178331	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.58	CHEMBL2598	Homo sapiens	Inhibition	%	0.58
	8178682	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.87	CHEMBL2598	Homo sapiens	Inhibition	%	1.87
	8178831	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.55	CHEMBL2598	Homo sapiens	Inhibition	%	3.55
	8179178	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.17	CHEMBL2598	Homo sapiens	Inhibition	%	3.17
	8179322	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-9.87	CHEMBL2598	Homo sapiens	Inhibition	%	-9.87
	8179546	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.34	CHEMBL2598	Homo sapiens	Inhibition	%	1.34
	8179683	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.67	CHEMBL2598	Homo sapiens	Inhibition	%	1.67
	8179940	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.28	CHEMBL2598	Homo sapiens	Inhibition	%	2.28
	8180318	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.76	CHEMBL2598	Homo sapiens	Inhibition	%	1.76
	8180474	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	27.46	CHEMBL2598	Homo sapiens	Inhibition	%	27.46
	8180846	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.5	CHEMBL2598	Homo sapiens	Inhibition	%	1.5
	8180979	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.04	CHEMBL2598	Homo sapiens	Inhibition	%	3.04
	8181203	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.3	CHEMBL2598	Homo sapiens	Inhibition	%	1.3
	8181334	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.37	CHEMBL2598	Homo sapiens	Inhibition	%	-0.37
	8181698	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.86	CHEMBL2598	Homo sapiens	Inhibition	%	2.86
	8181837	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.15	CHEMBL2598	Homo sapiens	Inhibition	%	0.15
	8182224	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.59	CHEMBL2598	Homo sapiens	Inhibition	%	1.59
	8182364	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.34	CHEMBL2598	Homo sapiens	Inhibition	%	0.34
	8182588	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.68	CHEMBL2598	Homo sapiens	Inhibition	%	3.68
	8182680	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.07	CHEMBL2598	Homo sapiens	Inhibition	%	1.07
	8183026	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.45	CHEMBL2598	Homo sapiens	Inhibition	%	1.45
	8183175	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.8	CHEMBL2598	Homo sapiens	Inhibition	%	1.8
	8183399	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.38	CHEMBL2598	Homo sapiens	Inhibition	%	3.38
	8183528	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.58	CHEMBL2598	Homo sapiens	Inhibition	%	6.58
	8183894	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.02	CHEMBL2598	Homo sapiens	Inhibition	%	1.02
	8184030	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.59	CHEMBL2598	Homo sapiens	Inhibition	%	-0.59
	8184254	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.06	CHEMBL2598	Homo sapiens	Inhibition	%	2.06
	8184296	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.85	CHEMBL2598	Homo sapiens	Inhibition	%	0.85
	8184520	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.16	CHEMBL2598	Homo sapiens	Inhibition	%	1.16
	8184667	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.59	CHEMBL2598	Homo sapiens	Inhibition	%	1.59
	8184824	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.67	CHEMBL2598	Homo sapiens	Inhibition	%	0.67
	8185048	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.27	CHEMBL2598	Homo sapiens	Inhibition	%	3.27
	8185197	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.84	CHEMBL2598	Homo sapiens	Inhibition	%	0.84
	8185552	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.69	CHEMBL2598	Homo sapiens	Inhibition	%	2.69
	8185683	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.02	CHEMBL2598	Homo sapiens	Inhibition	%	0.02
	8185907	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.64	CHEMBL2598	Homo sapiens	Inhibition	%	0.64
	8186046	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.51	CHEMBL2598	Homo sapiens	Inhibition	%	3.51
	8186187	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.96	CHEMBL2598	Homo sapiens	Inhibition	%	1.96
	8186411	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8186575	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.04	CHEMBL2598	Homo sapiens	Inhibition	%	2.04
	8186938	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.77	CHEMBL2598	Homo sapiens	Inhibition	%	1.77
	8187036	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.54	CHEMBL2598	Homo sapiens	Inhibition	%	0.54
	8187260	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.6	CHEMBL2598	Homo sapiens	Inhibition	%	1.6
	8187384	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.36	CHEMBL2598	Homo sapiens	Inhibition	%	2.36
	8187756	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.1	CHEMBL2598	Homo sapiens	Inhibition	%	2.1
	8187885	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.53	CHEMBL2598	Homo sapiens	Inhibition	%	3.53
	8188109	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.77	CHEMBL2598	Homo sapiens	Inhibition	%	2.77
	8188252	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.75	CHEMBL2598	Homo sapiens	Inhibition	%	0.75
	8188611	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.98	CHEMBL2598	Homo sapiens	Inhibition	%	0.98
	8188885	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8189033	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.94	CHEMBL2598	Homo sapiens	Inhibition	%	1.94
	8189413	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.82	CHEMBL2598	Homo sapiens	Inhibition	%	1.82
	8189562	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.45	CHEMBL2598	Homo sapiens	Inhibition	%	0.45
	8189918	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.19	CHEMBL2598	Homo sapiens	Inhibition	%	1.19
	8190274	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.57	CHEMBL2598	Homo sapiens	Inhibition	%	2.57
	8190414	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.83	CHEMBL2598	Homo sapiens	Inhibition	%	2.83
	8190775	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.02	CHEMBL2598	Homo sapiens	Inhibition	%	1.02
	8190939	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.17	CHEMBL2598	Homo sapiens	Inhibition	%	2.17
	8191301	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.15	CHEMBL2598	Homo sapiens	Inhibition	%	4.15
	8191621	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.0	CHEMBL2598	Homo sapiens	Inhibition	%	1.0
	8191743	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.45	CHEMBL2598	Homo sapiens	Inhibition	%	1.45
	8191967	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8192116	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.47	CHEMBL2598	Homo sapiens	Inhibition	%	3.47
	8192469	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.76	CHEMBL2598	Homo sapiens	Inhibition	%	0.76
	8192613	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.25	CHEMBL2598	Homo sapiens	Inhibition	%	0.25
	8192973	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.79	CHEMBL2598	Homo sapiens	Inhibition	%	1.79
	8193245	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.73	CHEMBL2598	Homo sapiens	Inhibition	%	0.73
	8193390	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.52	CHEMBL2598	Homo sapiens	Inhibition	%	1.52
	8193614	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.15	CHEMBL2598	Homo sapiens	Inhibition	%	1.15
	8193771	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.43	CHEMBL2598	Homo sapiens	Inhibition	%	2.43
	8193920	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.51	CHEMBL2598	Homo sapiens	Inhibition	%	0.51
	8194144	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.25	CHEMBL2598	Homo sapiens	Inhibition	%	-0.25
	8194275	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.5	CHEMBL2598	Homo sapiens	Inhibition	%	3.5
	8194630	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.4	CHEMBL2598	Homo sapiens	Inhibition	%	1.4
	8194773	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.85	CHEMBL2598	Homo sapiens	Inhibition	%	4.85
	8194997	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.13	CHEMBL2598	Homo sapiens	Inhibition	%	2.13
	8195130	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.08	CHEMBL2598	Homo sapiens	Inhibition	%	1.08
	8195294	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.4	CHEMBL2598	Homo sapiens	Inhibition	%	4.4
	8195518	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-0.01	CHEMBL2598	Homo sapiens	Inhibition	%	-0.01
	8195657	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.1	CHEMBL2598	Homo sapiens	Inhibition	%	2.1
	8195979	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.59	CHEMBL2598	Homo sapiens	Inhibition	%	1.59
	8196320	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.68	CHEMBL2598	Homo sapiens	Inhibition	%	0.68
	8196470	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.43	CHEMBL2598	Homo sapiens	Inhibition	%	1.43
	8196822	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.66	CHEMBL2598	Homo sapiens	Inhibition	%	2.66
	8196963	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.08	CHEMBL2598	Homo sapiens	Inhibition	%	1.08
	8197187	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.19	CHEMBL2598	Homo sapiens	Inhibition	%	0.19
	8197324	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.03	CHEMBL2598	Homo sapiens	Inhibition	%	-0.03
	8197599	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.87	CHEMBL2598	Homo sapiens	Inhibition	%	0.87
	8197963	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.82	CHEMBL2598	Homo sapiens	Inhibition	%	0.82
	8198120	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.39	CHEMBL2598	Homo sapiens	Inhibition	%	2.39
	8198482	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.53	CHEMBL2598	Homo sapiens	Inhibition	%	2.53
	8198612	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.78	CHEMBL2598	Homo sapiens	Inhibition	%	1.78
	8198836	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.73	CHEMBL2598	Homo sapiens	Inhibition	%	2.73
	8198967	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.19	CHEMBL2598	Homo sapiens	Inhibition	%	3.19
	8199339	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.77	CHEMBL2598	Homo sapiens	Inhibition	%	2.77
	8199473	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.11	CHEMBL2598	Homo sapiens	Inhibition	%	1.11
	8199860	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.97	CHEMBL2598	Homo sapiens	Inhibition	%	2.97
	8199998	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.65	CHEMBL2598	Homo sapiens	Inhibition	%	3.65
	8200222	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.29	CHEMBL2598	Homo sapiens	Inhibition	%	2.29
	8200326	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.23	CHEMBL2598	Homo sapiens	Inhibition	%	0.23
	8200665	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.83	CHEMBL2598	Homo sapiens	Inhibition	%	2.83
	8200815	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.68	CHEMBL2598	Homo sapiens	Inhibition	%	3.68
	8201039	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.79	CHEMBL2598	Homo sapiens	Inhibition	%	1.79
	8201169	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.01	CHEMBL2598	Homo sapiens	Inhibition	%	0.01
	8201528	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.28	CHEMBL2598	Homo sapiens	Inhibition	%	0.28
	8201661	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.41	CHEMBL2598	Homo sapiens	Inhibition	%	0.41
	8201940	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.77	CHEMBL2598	Homo sapiens	Inhibition	%	2.77
	8202304	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.79	CHEMBL2598	Homo sapiens	Inhibition	%	0.79
	8202471	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.4	CHEMBL2598	Homo sapiens	Inhibition	%	2.4
	8202820	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.58	CHEMBL2598	Homo sapiens	Inhibition	%	0.58
	8203174	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.63	CHEMBL2598	Homo sapiens	Inhibition	%	2.63
	8203305	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.66	CHEMBL2598	Homo sapiens	Inhibition	%	1.66
	8203675	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.92	CHEMBL2598	Homo sapiens	Inhibition	%	0.92
	8203809	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.75	CHEMBL2598	Homo sapiens	Inhibition	%	0.75
	8204033	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.68	CHEMBL2598	Homo sapiens	Inhibition	%	1.68
	8204199	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.22	CHEMBL2598	Homo sapiens	Inhibition	%	0.22
	8204560	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.56	CHEMBL2598	Homo sapiens	Inhibition	%	4.56
	8204665	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.46	CHEMBL2598	Homo sapiens	Inhibition	%	0.46
	8204889	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.05	CHEMBL2598	Homo sapiens	Inhibition	%	1.05
	8205004	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.53	CHEMBL2598	Homo sapiens	Inhibition	%	2.53
	8205377	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.89	CHEMBL2598	Homo sapiens	Inhibition	%	3.89
	8205513	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.07	CHEMBL2598	Homo sapiens	Inhibition	%	3.07
	8205876	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.93	CHEMBL2598	Homo sapiens	Inhibition	%	0.93
	8206008	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.63	CHEMBL2598	Homo sapiens	Inhibition	%	-0.63
	8206232	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.06	CHEMBL2598	Homo sapiens	Inhibition	%	-1.06
	8206284	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8206508	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.2	CHEMBL2598	Homo sapiens	Inhibition	%	2.2
	8206651	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.34	CHEMBL2598	Homo sapiens	Inhibition	%	0.34
	8206831	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.62	CHEMBL2598	Homo sapiens	Inhibition	%	2.62
	8207055	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.77	CHEMBL2598	Homo sapiens	Inhibition	%	3.77
	8207181	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.71	CHEMBL2598	Homo sapiens	Inhibition	%	2.71
	8207535	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.33	CHEMBL2598	Homo sapiens	Inhibition	%	5.33
	8207667	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.75	CHEMBL2598	Homo sapiens	Inhibition	%	2.75
	8207891	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.51	CHEMBL2598	Homo sapiens	Inhibition	%	2.51
	8208036	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.4	CHEMBL2598	Homo sapiens	Inhibition	%	4.4
	8208392	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.87	CHEMBL2598	Homo sapiens	Inhibition	%	0.87
	8208558	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.06	CHEMBL2598	Homo sapiens	Inhibition	%	1.06
	8208915	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.95	CHEMBL2598	Homo sapiens	Inhibition	%	1.95
	8209244	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.5	CHEMBL2598	Homo sapiens	Inhibition	%	3.5
	8209360	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.73	CHEMBL2598	Homo sapiens	Inhibition	%	2.73
	8209734	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.06	CHEMBL2598	Homo sapiens	Inhibition	%	1.06
	8209870	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.84	CHEMBL2598	Homo sapiens	Inhibition	%	0.84
	8210094	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.97	CHEMBL2598	Homo sapiens	Inhibition	%	2.97
	8210235	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.03	CHEMBL2598	Homo sapiens	Inhibition	%	-0.03
	8210595	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.0	CHEMBL2598	Homo sapiens	Inhibition	%	-1.0
	8210854	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.35	CHEMBL2598	Homo sapiens	Inhibition	%	0.35
	8210998	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.97	CHEMBL2598	Homo sapiens	Inhibition	%	0.97
	8211392	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.82	CHEMBL2598	Homo sapiens	Inhibition	%	2.82
	8211515	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.25	CHEMBL2598	Homo sapiens	Inhibition	%	1.25
	8211739	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.87	CHEMBL2598	Homo sapiens	Inhibition	%	2.87
	8211868	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	19.23	CHEMBL2598	Homo sapiens	Inhibition	%	19.23
	8212224	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.39	CHEMBL2598	Homo sapiens	Inhibition	%	3.39
	8212365	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.42	CHEMBL2598	Homo sapiens	Inhibition	%	2.42
	8212722	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.19	CHEMBL2598	Homo sapiens	Inhibition	%	2.19
	8212892	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.77	CHEMBL2598	Homo sapiens	Inhibition	%	0.77
	8213116	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.87	CHEMBL2598	Homo sapiens	Inhibition	%	1.87
	8213245	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.79	CHEMBL2598	Homo sapiens	Inhibition	%	14.79
	8213573	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.12	CHEMBL2598	Homo sapiens	Inhibition	%	0.12
	8213686	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.17	CHEMBL2598	Homo sapiens	Inhibition	%	1.17
	8213910	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.25	CHEMBL2598	Homo sapiens	Inhibition	%	3.25
	8214057	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.22	CHEMBL2598	Homo sapiens	Inhibition	%	3.22
	8214418	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.22	CHEMBL2598	Homo sapiens	Inhibition	%	0.22
	8214552	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.56	CHEMBL2598	Homo sapiens	Inhibition	%	1.56
	8214776	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.31	CHEMBL2598	Homo sapiens	Inhibition	%	-0.31
	8214928	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.68	CHEMBL2598	Homo sapiens	Inhibition	%	3.68
	8215179	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.1	CHEMBL2598	Homo sapiens	Inhibition	%	3.1
	8215332	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.66	CHEMBL2598	Homo sapiens	Inhibition	%	2.66
	8215556	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.44	CHEMBL2598	Homo sapiens	Inhibition	%	1.44
	8215720	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.06	CHEMBL2598	Homo sapiens	Inhibition	%	3.06
	8216063	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.36	CHEMBL2598	Homo sapiens	Inhibition	%	0.36
	8216182	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.8	CHEMBL2598	Homo sapiens	Inhibition	%	0.8
	8216542	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.01	CHEMBL2598	Homo sapiens	Inhibition	%	2.01
	8216680	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.67	CHEMBL2598	Homo sapiens	Inhibition	%	3.67
	8216904	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.2	CHEMBL2598	Homo sapiens	Inhibition	%	3.2
	8217038	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.94	CHEMBL2598	Homo sapiens	Inhibition	%	1.94
	8217436	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.57	CHEMBL2598	Homo sapiens	Inhibition	%	0.57
	8217567	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.06	CHEMBL2598	Homo sapiens	Inhibition	%	2.06
	8217892	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.71	CHEMBL2598	Homo sapiens	Inhibition	%	3.71
	8218231	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.37	CHEMBL2598	Homo sapiens	Inhibition	%	3.37
	8218358	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.38	CHEMBL2598	Homo sapiens	Inhibition	%	2.38
	8218582	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	10.31	CHEMBL2598	Homo sapiens	Inhibition	%	10.31
	8218725	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.51	CHEMBL2598	Homo sapiens	Inhibition	%	3.51
	8219080	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.82	CHEMBL2598	Homo sapiens	Inhibition	%	1.82
	8219240	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.56	CHEMBL2598	Homo sapiens	Inhibition	%	4.56
	8219490	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.21	CHEMBL2598	Homo sapiens	Inhibition	%	3.21
	8219875	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.36	CHEMBL2598	Homo sapiens	Inhibition	%	3.36
	8220044	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.02	CHEMBL2598	Homo sapiens	Inhibition	%	2.02
	8220397	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.84	CHEMBL2598	Homo sapiens	Inhibition	%	2.84
	8220511	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.82	CHEMBL2598	Homo sapiens	Inhibition	%	0.82
	8220735	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.43	CHEMBL2598	Homo sapiens	Inhibition	%	1.43
	8220873	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.09	CHEMBL2598	Homo sapiens	Inhibition	%	4.09
	8221233	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.61	CHEMBL2598	Homo sapiens	Inhibition	%	15.61
	8221366	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.72	CHEMBL2598	Homo sapiens	Inhibition	%	0.72
	8221590	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.65	CHEMBL2598	Homo sapiens	Inhibition	%	0.65
	8221755	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.25	CHEMBL2598	Homo sapiens	Inhibition	%	0.25
	8221886	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.79	CHEMBL2598	Homo sapiens	Inhibition	%	3.79
	8222110	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.86	CHEMBL2598	Homo sapiens	Inhibition	%	1.86
	8222208	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.79	CHEMBL2598	Homo sapiens	Inhibition	%	1.79
	8222566	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.01	CHEMBL2598	Homo sapiens	Inhibition	%	2.01
	8222908	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.92	CHEMBL2598	Homo sapiens	Inhibition	%	1.92
	8223052	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.63	CHEMBL2598	Homo sapiens	Inhibition	%	0.63
	8223405	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.93	CHEMBL2598	Homo sapiens	Inhibition	%	0.93
	8223566	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.94	CHEMBL2598	Homo sapiens	Inhibition	%	0.94
	8223816	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.93	CHEMBL2598	Homo sapiens	Inhibition	%	3.93
	8224040	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.45	CHEMBL2598	Homo sapiens	Inhibition	%	3.45
	8224202	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.01	CHEMBL2598	Homo sapiens	Inhibition	%	2.01
	8224372	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.89	CHEMBL2598	Homo sapiens	Inhibition	%	2.89
	8224596	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.39	CHEMBL2598	Homo sapiens	Inhibition	%	-0.39
	8224731	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.46	CHEMBL2598	Homo sapiens	Inhibition	%	1.46
	8225069	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.11	CHEMBL2598	Homo sapiens	Inhibition	%	1.11
	8225203	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.37	CHEMBL2598	Homo sapiens	Inhibition	%	2.37
	8225427	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.83	CHEMBL2598	Homo sapiens	Inhibition	%	3.83
	8225565	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.19	CHEMBL2598	Homo sapiens	Inhibition	%	2.19
	8225924	CHEMBL1961906	GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.29	CHEMBL2598	Homo sapiens	Inhibition	%	1.29
	8226082	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.35	CHEMBL2598	Homo sapiens	Inhibition	%	1.35
	8226431	CHEMBL1961907	GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.2	CHEMBL2598	Homo sapiens	Inhibition	%	3.2
inactive	9623037	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623038	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623039	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623040	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623041	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623042	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9623043	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9623044	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623045	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623046	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623047	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623048	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623049	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623050	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623051	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623052	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623053	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623054	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623055	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623056	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623057	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623058	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623059	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623060	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9623061	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	31.62	CHEMBL2598	Homo sapiens	pKi		7.5
active	9623062	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9623063	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623064	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9623065	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	199.53	CHEMBL2598	Homo sapiens	pKi		6.7
inactive	9623066	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623067	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623068	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623069	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623070	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623071	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623072	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623073	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623074	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9623075	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9623076	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623077	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623078	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623079	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623080	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623081	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623082	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623083	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9623084	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626635	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626636	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626637	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626638	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626639	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626640	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626641	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626642	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626643	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626644	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626645	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626646	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9626647	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626648	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626649	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626650	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626651	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626652	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	63.1	CHEMBL2598	Homo sapiens	pKi		7.2
inactive	9626653	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626654	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626655	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626656	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626657	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626658	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626659	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626660	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626661	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626662	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626663	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626664	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626665	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626666	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626667	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626668	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626669	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626670	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626671	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626672	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626673	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626674	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626675	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626676	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626677	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626678	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626679	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626680	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626681	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626682	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	398.11	CHEMBL2598	Homo sapiens	pKi		6.4
inactive	9626683	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626684	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626685	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
active	9626686	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9626687	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626688	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626689	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9626690	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626691	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626692	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626693	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1584.89	CHEMBL2598	Homo sapiens	pKi		5.8
inactive	9626694	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626695	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626696	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626697	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626698	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626699	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
active	9626700	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1584.89	CHEMBL2598	Homo sapiens	pKi		5.8
inactive	9626701	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626702	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626703	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626704	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626705	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626706	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626707	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626708	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626709	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626710	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	251.19	CHEMBL2598	Homo sapiens	pKi		6.6
inactive	9626711	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626712	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626713	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626714	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626715	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626716	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626717	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626718	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626719	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626720	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626721	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626722	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626723	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626724	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626725	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626726	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626727	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626728	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626729	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626730	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626731	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626732	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626733	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9626734	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626735	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9626736	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626737	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626738	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626739	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626740	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626741	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
inactive	9626742	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626743	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9626744	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626745	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626746	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626747	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626748	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626749	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626750	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626751	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626752	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9626753	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626754	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626755	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626756	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626757	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
inactive	9626758	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626759	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626760	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626761	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626762	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9626763	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626764	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626765	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626766	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626767	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626768	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626769	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626770	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626771	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626772	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626773	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626774	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626775	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626776	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626777	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626778	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626779	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626780	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626781	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626782	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626783	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626784	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626785	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626786	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626787	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626788	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626789	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626790	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626791	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626792	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626793	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626794	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626795	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626796	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626797	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626798	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626799	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626800	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	1258.93	CHEMBL2598	Homo sapiens	pKi		5.9
inactive	9626801	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626802	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626803	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626804	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626805	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626806	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626807	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626808	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626809	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626810	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626811	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626812	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626813	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626814	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626815	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626816	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626817	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626818	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626819	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626820	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626821	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626822	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626823	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626824	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
inactive	9626825	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626826	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626827	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626828	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626829	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626830	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9626831	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626832	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9626833	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626834	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626835	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626836	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626837	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626838	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626839	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626840	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626841	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626842	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626843	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626844	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626845	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626846	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626847	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626848	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626849	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626850	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626851	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9626852	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626853	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626854	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9626855	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	794.33	CHEMBL2598	Homo sapiens	pKi		6.1
inactive	9626856	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626857	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626858	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626859	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626860	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626861	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626862	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626863	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626864	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626865	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626866	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9626867	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630432	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630433	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630434	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630435	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630436	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630437	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	1995.26	CHEMBL2598	Homo sapiens	pKi		5.7
inactive	9630438	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630439	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630440	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630441	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630442	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	501.19	CHEMBL2598	Homo sapiens	pKi		6.3
inactive	9630443	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630444	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630445	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630446	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630447	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630448	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630449	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630450	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630451	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630452	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630453	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630454	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630455	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630456	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630457	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630458	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630459	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630460	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630461	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630462	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630463	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630464	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630465	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630466	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630467	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630468	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630469	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630470	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630471	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630472	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9630473	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630474	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630475	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630476	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630477	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630478	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630479	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630480	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630481	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630482	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630483	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630484	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630485	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630486	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630487	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630488	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630489	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630490	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
active	9630491	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	1584.89	CHEMBL2598	Homo sapiens	pKi		5.8
inactive	9630492	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630493	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630494	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630495	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630496	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630497	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630498	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
inactive	9630499	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630500	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630501	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630502	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630503	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630504	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630505	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630506	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630507	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630508	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630509	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630510	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630511	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9630512	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630513	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630514	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630515	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630516	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630517	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630518	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630519	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630520	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630521	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630522	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630523	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630524	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630525	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630526	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
active	9630527	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1000.0	CHEMBL2598	Homo sapiens	pKi		6.0
inactive	9630528	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630529	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630530	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630531	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630532	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630533	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630534	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630535	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630536	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630537	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630538	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	31.62	CHEMBL2598	Homo sapiens	pKi		7.5
inactive	9630539	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630540	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630541	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630542	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630543	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9630544	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630545	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630546	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630547	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630548	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630549	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630550	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630551	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630552	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	398.11	CHEMBL2598	Homo sapiens	pKi		6.4
inactive	9630553	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630554	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9630555	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630556	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630557	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630558	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630559	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630560	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630561	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630562	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	794.33	CHEMBL2598	Homo sapiens	pKi		6.1
inactive	9630563	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630564	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630565	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630566	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630567	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630568	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630569	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630570	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630571	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630572	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630573	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630574	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630575	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630576	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630577	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630578	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630579	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630580	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	3.162	CHEMBL2598	Homo sapiens	pKi		8.5
inactive	9630581	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630582	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630583	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	3981.07	CHEMBL2598	Homo sapiens	pKi		5.4
inactive	9630584	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630585	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630586	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630587	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630588	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630589	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630590	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630591	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630592	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630593	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630594	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630595	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630596	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9630597	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630598	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630599	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630600	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630601	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630602	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630603	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630604	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630605	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630606	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630607	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630608	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630609	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630610	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630611	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630612	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630613	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630614	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630615	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630616	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	2511.89	CHEMBL2598	Homo sapiens	pKi		5.6
inactive	9630617	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630618	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630619	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	3162.28	CHEMBL2598	Homo sapiens	pKi		5.5
inactive	9630620	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630621	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630622	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630623	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630624	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630625	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630626	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630627	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	1995.26	CHEMBL2598	Homo sapiens	pKi		5.7
inactive	9630628	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
active	9630629	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1584.89	CHEMBL2598	Homo sapiens	pKi		5.8
inactive	9630630	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630631	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630632	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
inactive	9630633	CHEMBL1963798	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCI	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	5011.87	CHEMBL2598	Homo sapiens	pKi		5.3
	10839463	CHEMBL2015494	Inhibition of PKCi at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	9.0	CHEMBL2598	Homo sapiens	INH	%	9.0
	10867540	CHEMBL2027430	Inhibition of PKCiota at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL2598	Homo sapiens	INH	%	0.0
	12047319	CHEMBL2157430	Inhibition of PKCiota at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	3.7	CHEMBL2598	Homo sapiens	INH	%	3.7
	12074657	CHEMBL2161219	Inhibition of PKCiota at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	12081889	CHEMBL2166775	Inhibition of PKCiota	B	Oc1ccc2oc3ncc(O)c(-c4ccccc4)c3c2c1	Outside typical range	CHEMBL2163772	>	Ki	nM	1000000.0	CHEMBL2598	Homo sapiens	Ki	uM	1000.0
	12152496	CHEMBL2182400	Inhibition of PKCiota assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	Activity	%	99.0	CHEMBL2598	Homo sapiens	Activity	%	99.0
	12152511	CHEMBL2182400	Inhibition of PKCiota assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	=	Activity	%	69.0	CHEMBL2598	Homo sapiens	Activity	%	69.0
	12172250	CHEMBL2212480	Inhibition of PRKCI assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	73.0	CHEMBL2598	Homo sapiens	Activity	%	73.0
	12254182	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12254183	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	116.0	CHEMBL2598	Homo sapiens	Residual Activity	%	116.0
	12254184	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL2598	Homo sapiens	Residual Activity	%	97.0
	12254185	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12254186	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL2598	Homo sapiens	Residual Activity	%	94.0
	12254187	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12254188	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12254189	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12254190	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	97.0	CHEMBL2598	Homo sapiens	Residual Activity	%	97.0
	12254191	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12254192	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12254193	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	91.0	CHEMBL2598	Homo sapiens	Residual Activity	%	91.0
	12254194	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12254195	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12254196	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12254197	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12254198	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12254199	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	98.0	CHEMBL2598	Homo sapiens	Residual Activity	%	98.0
	12254200	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12254201	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12254202	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12254203	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	91.0	CHEMBL2598	Homo sapiens	Residual Activity	%	91.0
	12254204	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12254205	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12254206	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12254207	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12254208	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12254209	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255617	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255618	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL2598	Homo sapiens	Residual Activity	%	86.0
	12255619	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255620	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255621	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255622	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	85.0	CHEMBL2598	Homo sapiens	Residual Activity	%	85.0
	12255623	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	97.0	CHEMBL2598	Homo sapiens	Residual Activity	%	97.0
	12255624	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	77.0	CHEMBL2598	Homo sapiens	Residual Activity	%	77.0
	12255625	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255626	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255627	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	85.0	CHEMBL2598	Homo sapiens	Residual Activity	%	85.0
	12255628	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255629	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	94.0	CHEMBL2598	Homo sapiens	Residual Activity	%	94.0
	12255630	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255631	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	80.0	CHEMBL2598	Homo sapiens	Residual Activity	%	80.0
	12255632	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255633	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255634	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255635	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255636	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	79.0	CHEMBL2598	Homo sapiens	Residual Activity	%	79.0
	12255637	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255638	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255639	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255640	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255641	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	85.0	CHEMBL2598	Homo sapiens	Residual Activity	%	85.0
	12255642	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL2598	Homo sapiens	Residual Activity	%	82.0
	12255643	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255644	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255645	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255646	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255647	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255648	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12255649	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	85.0	CHEMBL2598	Homo sapiens	Residual Activity	%	85.0
	12255650	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	79.0	CHEMBL2598	Homo sapiens	Residual Activity	%	79.0
	12255651	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255652	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255653	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12255654	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12255655	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12255656	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12255657	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255658	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255659	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	83.0	CHEMBL2598	Homo sapiens	Residual Activity	%	83.0
	12255660	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255661	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	74.0	CHEMBL2598	Homo sapiens	Residual Activity	%	74.0
	12255662	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	95.0	CHEMBL2598	Homo sapiens	Residual Activity	%	95.0
	12255663	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255664	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255665	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255666	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255667	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	82.0	CHEMBL2598	Homo sapiens	Residual Activity	%	82.0
	12255668	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	50.0	CHEMBL2598	Homo sapiens	Residual Activity	%	50.0
	12255669	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255670	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255671	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255672	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255673	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255674	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	114.0	CHEMBL2598	Homo sapiens	Residual Activity	%	114.0
	12255675	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255676	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255677	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	117.0	CHEMBL2598	Homo sapiens	Residual Activity	%	117.0
	12255678	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12255679	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255680	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12255681	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12255682	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	120.0	CHEMBL2598	Homo sapiens	Residual Activity	%	120.0
	12255683	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	113.0	CHEMBL2598	Homo sapiens	Residual Activity	%	113.0
	12255684	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255685	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	111.0	CHEMBL2598	Homo sapiens	Residual Activity	%	111.0
	12255686	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255687	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255688	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL2598	Homo sapiens	Residual Activity	%	104.0
	12255689	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255690	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255691	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL2598	Homo sapiens	Residual Activity	%	114.0
	12255692	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12255693	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	104.0	CHEMBL2598	Homo sapiens	Residual Activity	%	104.0
	12255694	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255695	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255696	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12255697	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12255698	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12255699	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255700	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12255701	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255702	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12255703	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255704	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255705	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255706	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	117.0	CHEMBL2598	Homo sapiens	Residual Activity	%	117.0
	12255707	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	113.0	CHEMBL2598	Homo sapiens	Residual Activity	%	113.0
	12255708	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255709	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	114.0	CHEMBL2598	Homo sapiens	Residual Activity	%	114.0
	12255710	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255711	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255712	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255713	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	113.0	CHEMBL2598	Homo sapiens	Residual Activity	%	113.0
	12255714	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	116.0	CHEMBL2598	Homo sapiens	Residual Activity	%	116.0
	12255715	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12255716	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255717	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12255718	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12255719	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12255720	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255721	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	117.0	CHEMBL2598	Homo sapiens	Residual Activity	%	117.0
	12255722	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	118.0	CHEMBL2598	Homo sapiens	Residual Activity	%	118.0
	12255723	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	114.0	CHEMBL2598	Homo sapiens	Residual Activity	%	114.0
	12255724	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12255725	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255726	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255727	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255728	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255729	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255730	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255731	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255732	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12255733	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255734	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255735	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	104.0	CHEMBL2598	Homo sapiens	Residual Activity	%	104.0
	12255736	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255737	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	113.0	CHEMBL2598	Homo sapiens	Residual Activity	%	113.0
	12255738	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255739	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255740	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12255741	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255742	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	104.0	CHEMBL2598	Homo sapiens	Residual Activity	%	104.0
	12255743	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255744	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	113.0	CHEMBL2598	Homo sapiens	Residual Activity	%	113.0
	12255745	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255746	CHEMBL2219117	Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12255747	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12255748	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	79.0	CHEMBL2598	Homo sapiens	Residual Activity	%	79.0
	12255749	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	111.0	CHEMBL2598	Homo sapiens	Residual Activity	%	111.0
	12255750	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	86.0	CHEMBL2598	Homo sapiens	Residual Activity	%	86.0
	12255751	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255752	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL2598	Homo sapiens	Residual Activity	%	98.0
	12255753	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255754	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	95.0	CHEMBL2598	Homo sapiens	Residual Activity	%	95.0
	12255755	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255756	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255757	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255758	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	72.0	CHEMBL2598	Homo sapiens	Residual Activity	%	72.0
	12255759	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255760	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	82.0	CHEMBL2598	Homo sapiens	Residual Activity	%	82.0
	12255761	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255762	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255763	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255764	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255765	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255766	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	86.0	CHEMBL2598	Homo sapiens	Residual Activity	%	86.0
	12255767	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12255768	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255769	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255770	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12255771	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL2598	Homo sapiens	Residual Activity	%	91.0
	12255772	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	95.0	CHEMBL2598	Homo sapiens	Residual Activity	%	95.0
	12255773	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12255774	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255775	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255776	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	87.0	CHEMBL2598	Homo sapiens	Residual Activity	%	87.0
	12255777	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL2598	Homo sapiens	Residual Activity	%	91.0
	12255778	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255779	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255780	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	97.0	CHEMBL2598	Homo sapiens	Residual Activity	%	97.0
	12255781	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12255782	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	72.0	CHEMBL2598	Homo sapiens	Residual Activity	%	72.0
	12255783	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	97.0	CHEMBL2598	Homo sapiens	Residual Activity	%	97.0
	12255784	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	77.0	CHEMBL2598	Homo sapiens	Residual Activity	%	77.0
	12255785	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255786	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255787	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12255788	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12255789	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	91.0	CHEMBL2598	Homo sapiens	Residual Activity	%	91.0
	12255790	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	77.0	CHEMBL2598	Homo sapiens	Residual Activity	%	77.0
	12255791	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	82.0	CHEMBL2598	Homo sapiens	Residual Activity	%	82.0
	12255792	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	67.0	CHEMBL2598	Homo sapiens	Residual Activity	%	67.0
	12255793	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255794	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255795	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	70.0	CHEMBL2598	Homo sapiens	Residual Activity	%	70.0
	12255796	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	84.0	CHEMBL2598	Homo sapiens	Residual Activity	%	84.0
	12255797	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	62.0	CHEMBL2598	Homo sapiens	Residual Activity	%	62.0
	12255798	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255799	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	73.0	CHEMBL2598	Homo sapiens	Residual Activity	%	73.0
	12255800	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	75.0	CHEMBL2598	Homo sapiens	Residual Activity	%	75.0
	12255801	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255802	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	77.0	CHEMBL2598	Homo sapiens	Residual Activity	%	77.0
	12255803	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	66.0	CHEMBL2598	Homo sapiens	Residual Activity	%	66.0
	12255804	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	81.0	CHEMBL2598	Homo sapiens	Residual Activity	%	81.0
	12255805	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	79.0	CHEMBL2598	Homo sapiens	Residual Activity	%	79.0
	12255806	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	63.0	CHEMBL2598	Homo sapiens	Residual Activity	%	63.0
	12255807	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	83.0	CHEMBL2598	Homo sapiens	Residual Activity	%	83.0
	12255808	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	85.0	CHEMBL2598	Homo sapiens	Residual Activity	%	85.0
	12255809	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	75.0	CHEMBL2598	Homo sapiens	Residual Activity	%	75.0
	12255810	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	73.0	CHEMBL2598	Homo sapiens	Residual Activity	%	73.0
	12255811	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	69.0	CHEMBL2598	Homo sapiens	Residual Activity	%	69.0
	12255812	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255813	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	71.0	CHEMBL2598	Homo sapiens	Residual Activity	%	71.0
	12255814	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	71.0	CHEMBL2598	Homo sapiens	Residual Activity	%	71.0
	12255815	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL2598	Homo sapiens	Residual Activity	%	88.0
	12255816	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	76.0	CHEMBL2598	Homo sapiens	Residual Activity	%	76.0
	12255817	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	78.0	CHEMBL2598	Homo sapiens	Residual Activity	%	78.0
	12255818	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	77.0	CHEMBL2598	Homo sapiens	Residual Activity	%	77.0
	12255819	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	47.0	CHEMBL2598	Homo sapiens	Residual Activity	%	47.0
	12255820	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	68.0	CHEMBL2598	Homo sapiens	Residual Activity	%	68.0
	12255821	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	71.0	CHEMBL2598	Homo sapiens	Residual Activity	%	71.0
	12255822	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	65.0	CHEMBL2598	Homo sapiens	Residual Activity	%	65.0
	12255823	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	80.0	CHEMBL2598	Homo sapiens	Residual Activity	%	80.0
	12255824	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	79.0	CHEMBL2598	Homo sapiens	Residual Activity	%	79.0
	12255825	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	68.0	CHEMBL2598	Homo sapiens	Residual Activity	%	68.0
	12255826	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	10.0	CHEMBL2598	Homo sapiens	Residual Activity	%	10.0
	12255827	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	90.0	CHEMBL2598	Homo sapiens	Residual Activity	%	90.0
	12255828	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12255829	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12255830	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12255831	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	114.0	CHEMBL2598	Homo sapiens	Residual Activity	%	114.0
	12255832	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255833	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12255834	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL2598	Homo sapiens	Residual Activity	%	101.0
	12255835	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12255836	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12255837	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	80.0	CHEMBL2598	Homo sapiens	Residual Activity	%	80.0
	12255838	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12255839	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12255840	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	115.0	CHEMBL2598	Homo sapiens	Residual Activity	%	115.0
	12255841	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12255842	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12255843	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12255844	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12255845	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12255846	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12255847	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	52.0	CHEMBL2598	Homo sapiens	Residual Activity	%	52.0
	12255848	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	69.0	CHEMBL2598	Homo sapiens	Residual Activity	%	69.0
	12255849	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12255850	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257259	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	98.0	CHEMBL2598	Homo sapiens	Residual Activity	%	98.0
	12257260	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257261	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257262	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257263	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12257264	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12257265	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12257266	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257267	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	67.0	CHEMBL2598	Homo sapiens	Residual Activity	%	67.0
	12257268	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12257269	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	96.0	CHEMBL2598	Homo sapiens	Residual Activity	%	96.0
	12257270	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	19.0	CHEMBL2598	Homo sapiens	Residual Activity	%	19.0
	12257271	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12257272	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12257273	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12257274	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12257275	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	83.0	CHEMBL2598	Homo sapiens	Residual Activity	%	83.0
	12257276	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12257277	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257278	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12257279	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	111.0	CHEMBL2598	Homo sapiens	Residual Activity	%	111.0
	12257280	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12257281	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257282	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257283	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12257284	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	80.0	CHEMBL2598	Homo sapiens	Residual Activity	%	80.0
	12257285	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12257286	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12257287	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	107.0	CHEMBL2598	Homo sapiens	Residual Activity	%	107.0
	12257288	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	55.0	CHEMBL2598	Homo sapiens	Residual Activity	%	55.0
	12257289	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	99.0	CHEMBL2598	Homo sapiens	Residual Activity	%	99.0
	12257290	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	89.0	CHEMBL2598	Homo sapiens	Residual Activity	%	89.0
	12257291	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12257292	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257293	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	112.0	CHEMBL2598	Homo sapiens	Residual Activity	%	112.0
	12257294	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257295	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL2598	Homo sapiens	Residual Activity	%	108.0
	12257296	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12257297	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	92.0	CHEMBL2598	Homo sapiens	Residual Activity	%	92.0
	12257298	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	86.0	CHEMBL2598	Homo sapiens	Residual Activity	%	86.0
	12257299	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12257300	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	102.0	CHEMBL2598	Homo sapiens	Residual Activity	%	102.0
	12257301	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257302	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257303	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12257304	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257305	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	93.0	CHEMBL2598	Homo sapiens	Residual Activity	%	93.0
	12257306	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL2598	Homo sapiens	Residual Activity	%	100.0
	12257307	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL2598	Homo sapiens	Residual Activity	%	103.0
	12257308	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	109.0	CHEMBL2598	Homo sapiens	Residual Activity	%	109.0
	12257309	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	110.0	CHEMBL2598	Homo sapiens	Residual Activity	%	110.0
	12257310	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	111.0	CHEMBL2598	Homo sapiens	Residual Activity	%	111.0
	12257311	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL2598	Homo sapiens	Residual Activity	%	105.0
	12257312	CHEMBL2219118	Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	106.0	CHEMBL2598	Homo sapiens	Residual Activity	%	106.0
	12693187	CHEMBL2343430	Inhibition of PKCiota (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	12727684	CHEMBL2351397	Inhibition of PKCiota (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	99.0	CHEMBL2598	Homo sapiens	Activity	%	99.0
	12728970	CHEMBL2350146	Inhibition of PKCiota (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL2598	Homo sapiens	Activity	%	105.0
	12729851	CHEMBL2352436	Inhibition of PKCiota (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL2598	Homo sapiens	Activity	%	95.0
	12730113	CHEMBL2351397	Inhibition of PKCiota (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	93.0	CHEMBL2598	Homo sapiens	Activity	%	93.0
	13335247	CHEMBL2393914	Inhibition of atypical PKCiota (unknown origin) using CREBtide as substrate incubated for 1 hr measured every 2.5 mins by ADP Quest assay	B	CCOC(=O)c1c(-c2ccc3c(c2)OCO3)csc1N		CHEMBL2393450	=	IC50	nM	2000.0	CHEMBL2598	Homo sapiens	IC50	uM	2.0
	13335248	CHEMBL2393914	Inhibition of atypical PKCiota (unknown origin) using CREBtide as substrate incubated for 1 hr measured every 2.5 mins by ADP Quest assay	B	CCOC(=O)c1c(-c2ccc(N(C)C)cc2)csc1N		CHEMBL2393448	=	IC50	nM	900.0	CHEMBL2598	Homo sapiens	IC50	uM	0.9
	13335249	CHEMBL2393914	Inhibition of atypical PKCiota (unknown origin) using CREBtide as substrate incubated for 1 hr measured every 2.5 mins by ADP Quest assay	B	COc1cccc(COC(=O)c2c(-c3ccc(OC)c(OC)c3)csc2N)c1		CHEMBL2393431	=	IC50	nM	900.0	CHEMBL2598	Homo sapiens	IC50	uM	0.9
	13335250	CHEMBL2393914	Inhibition of atypical PKCiota (unknown origin) using CREBtide as substrate incubated for 1 hr measured every 2.5 mins by ADP Quest assay	B	COc1ccc(-c2csc(N)c2C(=O)OC(C)C)cc1OC		CHEMBL2393423	=	IC50	nM	5000.0	CHEMBL2598	Homo sapiens	IC50	uM	5.0
	13374377	CHEMBL2406508	Inhibition of PKCiota (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	23.0	CHEMBL2598	Homo sapiens	INH	%	23.0
	13871773	CHEMBL3101234	Inhibition of human PKCiota assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	92.0	CHEMBL2598	Homo sapiens	Activity	%	92.0
	14585300	CHEMBL3241654	Inhibition of human PKCiota assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	102.0	CHEMBL2598	Homo sapiens	Activity	%	102.0
	14659159	CHEMBL3269732	Inhibition of PKCepsilon (unknown origin)-Par6 interaction	B		Non standard unit for type	CHEMBL306043	=	INH	uM	10.0	CHEMBL2598	Homo sapiens	INH	uM	10.0
	14999324	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)cc2)C1		CHEMBL3323314	=	Inhibition	%	0.0	CHEMBL2598	Homo sapiens	INH	%	0.0
	14999325	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(O)cc2)C1		CHEMBL3323321	=	Inhibition	%	43.5	CHEMBL2598	Homo sapiens	INH	%	43.5
	14999326	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2cccc(F)c2)C(c2ccc(O)cc2)C1		CHEMBL3323322	=	Inhibition	%	19.3	CHEMBL2598	Homo sapiens	INH	%	19.3
	14999327	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2cccc(C(F)(F)F)c2)C(c2ccc(O)cc2)C1		CHEMBL3323323	=	Inhibition	%	17.0	CHEMBL2598	Homo sapiens	INH	%	17.0
	14999328	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Cc1cccc(N2N=C(C(C)(C)C)CC2c2ccc(O)cc2)c1		CHEMBL3323324	=	Inhibition	%	13.9	CHEMBL2598	Homo sapiens	INH	%	13.9
	14999329	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(F)c(Cl)c2)C(c2ccc(O)cc2)C1		CHEMBL3323330	=	Inhibition	%	31.6	CHEMBL2598	Homo sapiens	INH	%	31.6
	14999330	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(F)c(F)c2)C(c2ccc(O)cc2)C1		CHEMBL3323331	=	Inhibition	%	23.7	CHEMBL2598	Homo sapiens	INH	%	23.7
	14999331	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(F)c(F)c2F)C(c2ccc(O)cc2)C1		CHEMBL3323334	=	Inhibition	%	7.8	CHEMBL2598	Homo sapiens	INH	%	7.8
	14999332	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccc3)=NN2c2ccc(Cl)cc2)cc1		CHEMBL3323336	=	Inhibition	%	31.6	CHEMBL2598	Homo sapiens	INH	%	31.6
	14999333	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccc3)=NN2c2cccc(Cl)c2)cc1		CHEMBL3323337	=	Inhibition	%	45.5	CHEMBL2598	Homo sapiens	INH	%	45.5
	14999334	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccc3O)=NN2c2ccc(Cl)cc2)cc1		CHEMBL3323338	=	Inhibition	%	13.4	CHEMBL2598	Homo sapiens	INH	%	13.4
	14999335	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3cccs3)=NN2c2ccc(Br)cc2)cc1		CHEMBL3323343	=	Inhibition	%	21.4	CHEMBL2598	Homo sapiens	INH	%	21.4
	14999336	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3cccs3)=NN2c2ccc(C(F)(F)F)cc2)cc1		CHEMBL3323344	=	Inhibition	%	45.9	CHEMBL2598	Homo sapiens	INH	%	45.9
	14999337	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccn3)=NN2c2cccc(Cl)c2)cc1		CHEMBL3323345	=	Inhibition	%	24.1	CHEMBL2598	Homo sapiens	INH	%	24.1
	14999338	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccc[nH]3)=NN2c2cccc(Cl)c2)cc1		CHEMBL3323346	=	Inhibition	%	20.3	CHEMBL2598	Homo sapiens	INH	%	20.3
	14999339	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Nc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(O)cc3)C2)cc1		CHEMBL3323347	=	Inhibition	%	38.7	CHEMBL2598	Homo sapiens	INH	%	38.7
	14999340	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2cccc(O)c2)C1		CHEMBL3323353	=	Inhibition	%	17.4	CHEMBL2598	Homo sapiens	INH	%	17.4
	14999341	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)c(F)c2)C1		CHEMBL3323356	=	Inhibition	%	29.7	CHEMBL2598	Homo sapiens	INH	%	29.7
	14999342	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)c(Cl)c2)C1		CHEMBL3323357	=	Inhibition	%	0.0	CHEMBL2598	Homo sapiens	INH	%	0.0
	14999343	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccc3O)=NN2c2ccc(Cl)cc2)cc1O		CHEMBL3323359	=	Inhibition	%	44.1	CHEMBL2598	Homo sapiens	INH	%	44.1
	14999344	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccc(C2CC(c3ccccc3O)=NN2c2cccc(Cl)c2)cc1F		CHEMBL3323360	=	Inhibition	%	25.2	CHEMBL2598	Homo sapiens	INH	%	25.2
	14999345	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccccc1C1=NN(c2cccc(Cl)c2)C(c2cc(F)c(O)c(F)c2)C1		CHEMBL3323332	=	Inhibition	%	45.2	CHEMBL2598	Homo sapiens	INH	%	45.2
	14999346	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	Oc1ccccc1C1=NN(c2cccc(Cl)c2)C(c2ccc(O)c(F)c2F)C1		CHEMBL3323333	=	Inhibition	%	39.2	CHEMBL2598	Homo sapiens	INH	%	39.2
	14999347	CHEMBL3368444	Inhibition of PKCiota (unknown origin) at 20 uM	B	CC1C(c2ccccc2O)=NN(c2cccc(Cl)c2)C1c1ccc(O)c(F)c1		CHEMBL3323364	=	Inhibition	%	23.1	CHEMBL2598	Homo sapiens	INH	%	23.1
	15018672	CHEMBL3361564	Inhibition of PKC iota (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	16.0	CHEMBL2598	Homo sapiens	INH	%	16.0
	15756850	CHEMBL3630933	Inhibition of PKCiota (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	4.69	CHEMBL2598	Homo sapiens	INH	%	4.69
	15757873	CHEMBL3630933	Inhibition of PKCiota (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	9.85	CHEMBL2598	Homo sapiens	INH	%	9.85
	15758852	CHEMBL3630933	Inhibition of PKCiota (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.69	CHEMBL2598	Homo sapiens	INH	%	5.69
	16373794	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)[Si](C)(C)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731951	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373795	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3cc[nH]c3)csc12)Cc1ccccc1		CHEMBL3731795	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373796	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccc[nH]3)csc12)Cc1ccccc1		CHEMBL3727941	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373797	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccsc1-c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729436	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373798	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)c1		CHEMBL3731749	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373799	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)Cn1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)cn1		CHEMBL3730403	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373800	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3cn[nH]c3)csc12)Cc1ccccc1		CHEMBL3728749	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373801	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1noc(C)c1-c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729655	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373802	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cn1nccc1-c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728993	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373803	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccn[nH]3)csc12)Cc1ccccc1		CHEMBL3727413	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373804	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(-c2ccn[nH]2)sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3729908	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373805	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccn[nH]1		CHEMBL3727824	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373806	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc2sc3c(N4CCNCC4)nc(-c4ccncc4)nc3c12		CHEMBL3731614	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373807	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12		CHEMBL3728477	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373808	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN(CCN)c1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12		CHEMBL3733020	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373809	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc2sc3c(N[C@@H]4CCNC4)nc(-c4ccncc4)nc3c12		CHEMBL3731633	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373810	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(C)c2c(n1)sc1c(NC[C@@H](C)N)nc(-c3ccncc3)nc12		CHEMBL3733109	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373811	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(C)c2c(n1)sc1c(NC[C@H](C)N)nc(-c3ccncc3)nc12		CHEMBL3732860	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373812	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(C)c2c(n1)sc1c(N3CCCNCC3)nc(-c3ccncc3)nc12		CHEMBL3728474	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373813	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(C)c2c(n1)sc1c(N3CCNCC3)nc(-c3ccncc3)nc12		CHEMBL3729415	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373814	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2c1sc1ncccc12		CHEMBL3732359	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373815	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1ccc(-c2cc3nc(-c4ccncc4)nc(NCCN)c3s2)cc1		CHEMBL3728557	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373816	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(NC[C@H](C)N)nc(-c3ccncc3)nc12		CHEMBL3727783	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373817	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(N3CCCNCC3)nc(-c3ccncc3)nc12		CHEMBL3727818	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373818	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(N3CCNCC3)nc(-c3ccncc3)nc12		CHEMBL3733186	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373819	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2c1sc1ncccc12		CHEMBL3729301	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373820	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cnc2sc3c(N4CCCNCC4)nc(-c4ccncc4)nc3c2c1		CHEMBL3730226	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373821	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cnc2sc3c(N4CCNCC4)nc(-c4ccncc4)nc3c2c1		CHEMBL3732646	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373822	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2c1sc1ncccc12		CHEMBL3728384	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373823	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12		CHEMBL3728698	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373824	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12		CHEMBL3729073	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373825	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12)Cc1ccccc1		CHEMBL3727488	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373826	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc2sc3c(N4CCCNCC4)nc(-c4ccncc4)nc3c12		CHEMBL3730030	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373827	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(NCCN)nc(-c3ccncc3)nc12		CHEMBL3730662	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373828	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2ccsc12)Cc1ccccc1		CHEMBL3729811	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373829	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1ccc(-c2cc3nc(-c4ccncc4)nc(N4CCCNCC4)c3s2)cc1		CHEMBL3727951	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373830	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1ccc(-c2cc3nc(-c4ccncc4)nc(N4CCNCC4)c3s2)cc1		CHEMBL3731732	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373831	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2cc(-c3ccc(C(C)(C)C)cc3)sc12		CHEMBL3731709	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373832	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2cc(-c3ccc(C(C)(C)C)cc3)sc12		CHEMBL3730433	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373833	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(NC[C@@H](C)N)nc(-c3ccncc3)nc12		CHEMBL3731918	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373834	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(-c2cc3nc(-c4ccncc4)nc(N4CCCNCC4)c3s2)cc1		CHEMBL3730295	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373835	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2cc(-c3ccccc3)sc12		CHEMBL3733327	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373836	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2cc(-c3ccccc3)sc12		CHEMBL3731602	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373837	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(N(C)CCN)nc(-c3ccncc3)nc12		CHEMBL3733358	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373838	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnccc1-c1nc(N[C@@H]2CCNC2)c2scc(Br)c2n1		CHEMBL3730731	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373839	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2F)nc2ccsc12		CHEMBL3732903	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373840	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnccc1-c1nc(N[C@@H]2CCNC2)c2sccc2n1		CHEMBL3729718	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373841	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3732660	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373842	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)[C@H](N)CNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3732347	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373843	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Br)csc12)CC1CCCCC1		CHEMBL3730525	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373844	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3732082	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373845	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(N3CCNCC3)nc(-c3ccncc3)nc12		CHEMBL3732296	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373846	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C[C@H](N)CNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3727886	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373847	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CNCCNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3732845	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373848	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(NC[C@@H]3CCCN3)nc(-c3ccncc3)nc12		CHEMBL3727923	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373849	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(NC[C@H]3CCCN3)nc(-c3ccncc3)nc12		CHEMBL3733256	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373850	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(N[C@@H]3CCCNC3)nc(-c3ccncc3)nc12		CHEMBL3732849	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373851	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Brc1csc2c(N[C@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3729098	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373852	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(N[C@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3730767	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373853	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(Br)sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3728387	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373854	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)CCNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3729827	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373855	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NC(=O)CNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3729990	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373856	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(Br)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731369	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373857	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Br)csc12)Cc1ccccc1		CHEMBL3727836	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373858	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1Br		CHEMBL3727626	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373859	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1Br		CHEMBL3728625	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373860	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NCCN)nc(-c3ccncc3)nc2c1Br		CHEMBL3730303	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373861	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(N[C@H]3CCNC3)nc(-c3ccncc3)nc2c1Br		CHEMBL3732559	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373862	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](C)N)nc(-c3ccncc3)nc2c1Br		CHEMBL3728254	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373863	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@H](C)N)nc(-c3ccncc3)nc2c1Br		CHEMBL3729448	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373864	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1Br		CHEMBL3729610	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373865	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc2c1Br		CHEMBL3728018	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16373866	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2c(-c3ccc(Br)cc3)csc12)Cc1ccccc1		CHEMBL3731582	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373867	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccc(Br)cc3)csc12)Cc1ccccc1		CHEMBL3730108	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373868	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cnccc1-c1nc(N[C@@H]2CCNC2)c2sccc2n1		CHEMBL3728734	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373869	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2Cl)nc2ccsc12)Cc1ccccc1		CHEMBL3731209	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16373870	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1cc2nc(-c3ccncc3)nc(NC[C@@H](N)Cc3ccccc3)c2s1		CHEMBL3727430	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16373871	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1C		CHEMBL3731903	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374174	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(NC[C@@H](N)Cc2ccccc2)c2c3c(sc2n1)CCCC3		CHEMBL3731302	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374175	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2cn[nH]c2)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3731001	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374176	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(NCCN)c2c3c(sc2n1)CCCC3		CHEMBL3731958	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374177	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2cn[nH]c2)nc2sc3c(c12)CCCC3		CHEMBL3728291	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374178	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(C[C@H](N)COc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)c1		CHEMBL3730597	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374179	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC[C@@H]3CCCCN3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3729868	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374180	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1c[nH]c2ccccc12		CHEMBL3728773	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374181	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C[C@H](N)COc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)cc1		CHEMBL3729318	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374182	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc2ccccc2c1		CHEMBL3730961	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374183	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccc2ccccc12		CHEMBL3728068	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374184	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC[C@H]3CCCCN3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3727444	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374185	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1csc2ccccc12		CHEMBL3730498	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374186	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1csc2ccccc12		CHEMBL3731393	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374187	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1c[nH]cn1		CHEMBL3729734	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374188	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccccc1C[C@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729122	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374189	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccc2ccccc12		CHEMBL3728861	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374190	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc2ccccc2c1		CHEMBL3731348	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374191	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc(Br)cc1		CHEMBL3728808	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374192	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccs1		CHEMBL3730803	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374193	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C[C@@H](N)COc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)cc1		CHEMBL3733074	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374194	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccs1		CHEMBL3729786	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374195	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CCc1ccccc1)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729835	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374196	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(C[C@H](N)COc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)cc1		CHEMBL3729288	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374197	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cccc(C[C@H](N)COc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)c1		CHEMBL3733354	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374198	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1F		CHEMBL3728311	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374199	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccc(F)c1		CHEMBL3728689	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374200	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc(F)cc1		CHEMBL3727805	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374201	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)CC1CCCCC1		CHEMBL3731304	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374202	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)C1CCCCC1		CHEMBL3728266	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374203	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)c1ccccc1		CHEMBL3732352	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374204	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC[C@@H]3CCCN3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3731452	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374205	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC[C@H]3CCCN3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3728937	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374206	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC3CNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3729503	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374207	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)[C@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729554	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374208	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3727756	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374209	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3731827	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374210	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)[C@@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728140	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374211	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)c1ccccc1		CHEMBL3731812	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374212	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C[C@@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728670	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374213	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729930	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374214	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3733037	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374215	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3730554	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374216	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3728413	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374217	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(OC3CCCNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3731222	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374218	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(O[C@H]3CCNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3729958	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374219	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(O[C@@H]3CCNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3729003	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374220	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C[C@H](N)COc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3732881	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374221	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CNCCOc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3731649	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374222	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCOc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728395	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374223	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)CCOc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3732709	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374224	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)CN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3731914	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374225	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCCN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3731848	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374226	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(CCN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3728850	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374227	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Brc1cnccc1CN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3729171	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374228	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cncc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)c1		CHEMBL3727641	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374229	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCCCN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3732036	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374230	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Brc1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cn1		CHEMBL3731306	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374231	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Brc1cccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)c1		CHEMBL3729934	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374232	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Oc1cccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)c1		CHEMBL3730622	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374233	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3729812	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374234	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)c1		CHEMBL3733000	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374235	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1ccccc1CN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3732034	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374236	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3731569	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374237	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	FC(F)(F)c1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3729153	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374238	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)nc1		CHEMBL3727608	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374239	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCN1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3729925	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374240	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)ccn1		CHEMBL3728737	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374241	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Brc1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3731142	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374242	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3730792	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374243	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(CN2CCN(c3nc(-c4ccncc4)nc4sc5c(c34)CCCC5)CC2)cc1		CHEMBL3728642	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374244	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)CN1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3730153	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374245	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3730511	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374246	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCN1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3729873	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374247	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)CC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3729595	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374248	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCCCC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3728994	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374249	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)C1CCC1)C3		CHEMBL3730886	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374250	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)C1CC1)C3		CHEMBL3732596	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374251	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3732977	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374252	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3733219	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374253	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3732553	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374254	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)OC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3728567	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374255	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2O)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3729676	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374256	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cnccc1-c1nc(NC[C@@H](N)Cc2ccccc2)c2c3c(sc2n1)CCCC3		CHEMBL3731978	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374257	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3732670	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374258	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2F)nc2sc3c(c12)CCCC3		CHEMBL3728676	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374259	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2F)nc2sc3c(c12)CCCC3		CHEMBL3729311	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374260	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccnc(F)c2)nc2sc3c(c12)CCCC3		CHEMBL3730624	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374261	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2F)nc2sc3c(c12)CCCC3		CHEMBL3727537	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374262	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)OC(C)(C)C)C3		CHEMBL3732476	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374263	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2nc(-c3ccncc3)nc(N3CCCNCC3)c12		CHEMBL3732514	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374264	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2nc(-c3ccncc3)nc(N3CCNCC3)c12		CHEMBL3731583	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374265	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Brc1ccc(-c2csc3nc(-c4ccncc4)nc(N4CCCNCC4)c23)cc1		CHEMBL3732696	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374266	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2nc(-c3ccncc3)nc(N3CCCNCC3)c2c1-c1ccccc1		CHEMBL3728274	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374267	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2nc(-c3ccncc3)nc(NCCN)c2c1-c1ccccc1		CHEMBL3732270	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374268	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)OC(=O)N1CCc2c(sc3nc(-c4ccncc4)nc(NC[C@@H](N)Cc4ccccc4)c23)C1		CHEMBL3732456	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374269	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCC3		CHEMBL3731862	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374270	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCC3		CHEMBL3728690	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374271	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCC3)Cc1ccccc1		CHEMBL3728988	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374272	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N3CCCNCC3)c3c4c(sc3n2)CCCCC4)ccn1		CHEMBL3732944	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374273	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N3CCNCC3)c3c4c(sc3n2)CCCCC4)ccn1		CHEMBL3732699	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374274	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCC3		CHEMBL3728024	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374275	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCOC3)Cc1ccccc1		CHEMBL3731407	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374276	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCOC3)Cc1ccccc1		CHEMBL3728657	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374277	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCSC3)Cc1ccccc1		CHEMBL3732291	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374278	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCSC3)Cc1ccccc1		CHEMBL3733094	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374279	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCC1(C3)OCCO1)Cc1ccccc1		CHEMBL3730360	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374280	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCC1(C3)OCCO1)Cc1ccccc1		CHEMBL3730311	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374281	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC1(C)CCc2c(sc3nc(-c4ccncc4)nc(NC[C@@H](N)Cc4ccccc4)c23)C1		CHEMBL3731902	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374282	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCCC3)Cc1ccccc1		CHEMBL3732346	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374283	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)c1cc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2s1		CHEMBL3729587	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374284	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(C(N)=O)sc2nc(-c3ccncc3)nc(NC[C@@H](N)Cc3ccccc3)c12		CHEMBL3733036	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374285	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)c1ccccc1)C3)Cc1ccccc1		CHEMBL3732003	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374286	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)c1ccccc1)C3)Cc1ccccc1		CHEMBL3731636	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374287	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3730647	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374288	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCC3)Cc1ccccc1		CHEMBL3728703	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374289	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC1CCc2c(sc3nc(-c4ccncc4)nc(NC[C@@H](N)Cc4ccccc4)c23)C1		CHEMBL3733184	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374290	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3732827	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374291	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1		CHEMBL3732675	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374292	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccc(O)c1		CHEMBL3729774	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374293	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1O		CHEMBL3729239	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374294	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccccc1C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCSC3		CHEMBL3729855	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374295	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1c[nH]c2ccccc12		CHEMBL3732000	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374296	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(NC[C@H]3CCCCN3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3732984	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374297	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1csc2ccccc12		CHEMBL3729541	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374298	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3732634	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374299	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cscn1		CHEMBL3729660	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374300	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccn1		CHEMBL3729839	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374301	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccnc1		CHEMBL3728077	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374302	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccncc1		CHEMBL3729897	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374303	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc(O)cc1		CHEMBL3731205	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374304	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(C[C@H](N)CNc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)c1		CHEMBL3728314	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374305	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccccc1C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728968	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374306	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1cccc2ccccc12		CHEMBL3730187	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374307	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccccc1F		CHEMBL3731344	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374308	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1ccc(F)cc1		CHEMBL3730055	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374309	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccccc1C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728164	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374310	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cccc(C[C@H](N)CNc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)c1		CHEMBL3727561	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374311	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C[C@H](N)CNc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)cc1		CHEMBL3728978	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374312	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(C[C@H](N)CNc2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)cc1		CHEMBL3730128	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374313	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCOC3		CHEMBL3727387	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374314	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCSC3		CHEMBL3728535	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374315	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC1(C)CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3732355	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374316	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCC1(C3)OCCO1		CHEMBL3730147	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374317	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)c1cc2c(NC[C@@H](C)N)nc(-c3ccncc3)nc2s1		CHEMBL3728284	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374318	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)c1cc2c(NCCN)nc(-c3ccncc3)nc2s1		CHEMBL3731554	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374319	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(C(N)=O)sc2nc(-c3ccncc3)nc(NCCN)c12		CHEMBL3728584	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374320	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2nc(-c3ccncc3)nc(NC[C@@H](C)N)c2c1C		CHEMBL3732937	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374321	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2nc(-c3ccncc3)nc(NC[C@H](C)N)c2c1C		CHEMBL3732811	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374322	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2nc(-c3ccncc3)nc(NCCN)c2c1C		CHEMBL3728050	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374323	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCc1cc2c(NC[C@@H](C)N)nc(-c3ccncc3)nc2s1		CHEMBL3727950	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374324	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCc1cc2c(NC[C@H](C)N)nc(-c3ccncc3)nc2s1		CHEMBL3731939	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374325	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCc1cc2c(NCCN)nc(-c3ccncc3)nc2s1		CHEMBL3731799	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374326	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCc1c(C)sc2nc(-c3ccncc3)nc(NC[C@@H](C)N)c12		CHEMBL3731387	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374327	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CCc1c(C)sc2nc(-c3ccncc3)nc(NC[C@H](C)N)c12		CHEMBL3730909	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374328	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)Cc1csc2nc(-c3ccncc3)nc(NC[C@@H](C)N)c12		CHEMBL3730639	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374329	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)Cc1csc2nc(-c3ccncc3)nc(NC[C@H](C)N)c12		CHEMBL3730633	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374330	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)Cc1csc2nc(-c3ccncc3)nc(NCCN)c12		CHEMBL3731728	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374331	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCN(C(=O)c1ccccc1)C3		CHEMBL3729869	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374332	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCCC3		CHEMBL3732957	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374333	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCCC3		CHEMBL3732747	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374334	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCCCCC3		CHEMBL3729159	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374335	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC1CCc2c(sc3nc(-c4ccncc4)nc(NC[C@@H](C)N)c23)C1		CHEMBL3733048	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374336	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC1CCc2c(sc3nc(-c4ccncc4)nc(NC[C@H](C)N)c23)C1		CHEMBL3731522	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374337	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC1CCc2c(sc3nc(-c4ccncc4)nc(NCCN)c23)C1		CHEMBL3727835	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374338	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@H]3CCNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3732226	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374339	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3733121	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374340	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N3C[C@@H]4C[C@H]3CN4)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3728576	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374341	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3730853	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374342	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3727406	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374343	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN(CCN)c1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728970	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374344	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N3CCCNCC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3728973	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374345	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CNCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3728294	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374346	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729516	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374347	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H]1C[C@@H]1Nc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3729071	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374348	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H]1CN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)[C@H](C)CN1		CHEMBL3732791	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374349	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H]1CN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)C[C@@H](C)N1		CHEMBL3732255	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374350	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H]1CN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CCN1		CHEMBL3732754	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374351	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3)Cc1c[nH]c2ccccc12		CHEMBL3728732	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374352	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CSCC[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3727609	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374353	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3733114	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374354	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL3731825	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374355	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N3CCNCC3)c3c4c(sc3n2)CCCC4)ccn1		CHEMBL3732444	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374356	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3732988	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374357	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)CCNc1nc(-c2ccncc2)nc2sc3c(c12)CCCC3		CHEMBL3730443	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374358	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	F[C@H]1NCC[C@H]1Nc1nc(-c2ccncc2)nc2ccsc12		CHEMBL3730369	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374359	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NC(=O)CN1CC[C@@H](Nc2nc(-c3ccncc3)nc3ccsc23)C1		CHEMBL3728561	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374360	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O[C@H]1CNC[C@@H]1Nc1nc(-c2ccncc2)nc2ccsc12		CHEMBL3729212	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374361	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H]1CCN(c2nc(-c3ccncc3)nc3ccsc23)C1		CHEMBL3729396	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374362	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3728330	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374363	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCCNC3)c3sccc3n2)ccn1		CHEMBL3729550	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374364	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	F[C@H]1CN(Cc2ccccc2)C[C@@H]1Nc1nc(-c2ccncc2)nc2ccsc12		CHEMBL3732934	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374365	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2ccsc12)Cc1ccccc1		CHEMBL3728884	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374366	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2cc(-c3ccccc3)sc12		CHEMBL3728146	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374367	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3732235	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374368	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1cc2nc(-c3ccncc3)nc(NCCN)c2s1		CHEMBL3730394	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374369	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCCNc1nc(-c2ccncc2)nc2c(-c3ccc(Br)cc3)csc12		CHEMBL3729853	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374370	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NCCN)nc(-c3ccncc3)nc2c1C		CHEMBL3727448	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374371	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2ccncc2)nc2cc(C(C)(C)C)sc12		CHEMBL3733206	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374372	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2cc(C(C)(C)C)sc12		CHEMBL3728764	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374373	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Cl)csc12)Cc1ccccc1		CHEMBL3727604	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374374	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2ccncc2)nc2c(Br)csc12		CHEMBL3729331	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374375	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(Br)csc12)Cc1ccccc1		CHEMBL3730322	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374376	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccccc1C[C@H](N)CNc1nc(-c2ccncc2)nc2c(Br)c(C(C)(C)C)sc12		CHEMBL3727866	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374377	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728548	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374378	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(-c2cc3nc(-c4ccncc4)nc(N4CCNCC4)c3s2)cc1		CHEMBL3730046	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374379	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1Br		CHEMBL3732473	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374380	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(C[C@H]2CN(c3nc(-c4cn[nH]c4)nc4sc5c(c34)CCCC5)CCN2)cc1		CHEMBL3731140	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374381	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cn1cc(-c2nc(NCCN)c3c4c(sc3n2)CCCC4)cn1		CHEMBL3728060	>	IC50	nM	60000.0	CHEMBL2598	Homo sapiens	IC50	uM	60.0
	16374382	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cn1cc(-c2nc(NCCN)c3c4c(sc3n2)CCCC4)cn1		CHEMBL3728060	>	IC50	nM	60000.0	CHEMBL2598	Homo sapiens	IC50	uM	60.0
	16374383	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(N[C@@H]2CCNC2)c2c3c(sc2n1)CCCC3		CHEMBL3731552	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374384	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(NC[C@@H](C)N)c2c3c(sc2n1)CCCC3		CHEMBL3733310	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374385	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(NC[C@H](C)N)c2c3c(sc2n1)CCCC3		CHEMBL3732178	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374386	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(N2CCCNCC2)c2c3c(sc2n1)CCCC3		CHEMBL3731624	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374387	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1n[nH]c(C)c1-c1nc(N2CCNCC2)c2c3c(sc2n1)CCCC3		CHEMBL3732901	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374388	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1n[nH]cc1-c1nc(N[C@@H]2CCNC2)c2c3c(sc2n1)CCCC3		CHEMBL3728079	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374389	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](N)CNc1nc(-c2cn[nH]c2)nc2sc3c(c12)CCCC3		CHEMBL3731690	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374390	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](N)CNc1nc(-c2cn[nH]c2)nc2sc3c(c12)CCCC3		CHEMBL3730379	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374391	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1n[nH]cc1-c1nc(N2CCCNCC2)c2c3c(sc2n1)CCCC3		CHEMBL3730408	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374392	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	c1n[nH]cc1-c1nc(N2CCNCC2)c2c3c(sc2n1)CCCC3		CHEMBL3733303	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374393	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COCC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728967	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374394	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCCC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728571	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374395	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#Cc3ccccc3)csc12)Cc1ccccc1		CHEMBL3731091	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374396	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3scc(-c4ccn[nH]4)c3n2)ccn1		CHEMBL3728975	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374397	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COC/C=C/c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729100	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374398	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(/C=C/C3CC3)csc12)Cc1ccccc1		CHEMBL3729268	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374399	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)/C=C/c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729728	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374400	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C/C=C\c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3732844	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374401	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C=Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728938	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374402	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccc(F)cc3)csc12)Cc1ccccc1		CHEMBL3731101	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374403	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3cccnc3)csc12)Cc1ccccc1		CHEMBL3731261	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374404	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cn1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)cn1		CHEMBL3732491	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374405	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)o1		CHEMBL3729295	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374406	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C3CC3)csc12)Cc1ccccc1		CHEMBL3732784	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374407	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](CNc1nc(-c2ccncc2)nc2c(-c3ccn[nH]3)csc12)Cc1ccccc1		CHEMBL3733230	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374408	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cn1ccc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)n1		CHEMBL3731857	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374409	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cc[nH]n3)csc12)Cc1ccccc1		CHEMBL3730628	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374410	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccccc3)csc12)Cc1ccccc1		CHEMBL3728652	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374411	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3cc(C4CC4)[nH]n3)csc12)Cc1ccccc1		CHEMBL3732273	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374412	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccc[nH]3)csc12)Cc1ccccc1		CHEMBL3731132	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374413	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cc[nH]c3)csc12)Cc1ccccc1		CHEMBL3731922	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374414	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cc(C(F)(F)F)[nH]n3)csc12)Cc1ccccc1		CHEMBL3731249	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374415	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cncnc3)csc12)Cc1ccccc1		CHEMBL3727961	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374416	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cccnc3)csc12)Cc1ccccc1		CHEMBL3727880	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374417	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccc(CO)cc3)csc12)Cc1ccccc1		CHEMBL3728424	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374418	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3cccc(CO)c3)csc12)Cc1ccccc1		CHEMBL3730885	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374419	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccoc3)csc12)Cc1ccccc1		CHEMBL3728051	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374420	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCc1ccc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4F)nc23)cc1		CHEMBL3729173	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374421	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1noc(C)c1-c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3F)nc12		CHEMBL3732246	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374422	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccncc3)csc12)Cc1ccccc1		CHEMBL3728500	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374423	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccc(F)cc3)csc12)Cc1ccccc1		CHEMBL3730943	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374424	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccsc3)csc12)Cc1ccccc1		CHEMBL3731215	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374425	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccco3)csc12)Cc1ccccc1		CHEMBL3730052	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374426	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccccc1-c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3F)nc12		CHEMBL3731044	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374427	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(-c3ccccc3)csc12)Cc1ccccc1		CHEMBL3727828	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374428	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NCc1coc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4F)nc23)c1		CHEMBL3727425	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374429	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1cccc(F)c1		CHEMBL3730428	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374430	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1cn[nH]c1		CHEMBL3727748	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374431	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccc(F)nc1		CHEMBL3731292	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374432	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccncc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728783	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374433	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(OC(C)C)c1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3732021	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374434	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(-c2c(C(C)(C)C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)c1		CHEMBL3730501	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374435	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccc(F)cc1		CHEMBL3732976	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374436	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccc(F)nc1		CHEMBL3731040	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374437	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1cccc(N)c1		CHEMBL3732193	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374438	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccoc1		CHEMBL3728900	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374439	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1cc(F)ccc1OC(C)C		CHEMBL3733338	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374440	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(-c2c(C(C)(C)C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)s1		CHEMBL3731347	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374441	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CNc1ccc(-c2c(C(C)(C)C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)cc1		CHEMBL3729747	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374442	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccccc1		CHEMBL3733276	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374443	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729904	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374444	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccccc1		CHEMBL3728132	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374445	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccccc3Cl)c(C(F)(F)F)sc12)Cc1ccccc1		CHEMBL3730907	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374446	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(Cl)c1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729433	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374447	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(OC)c1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731899	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374448	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(OCC(C)C)c1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731177	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374449	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cnccc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730206	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374450	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1nc(C)c(-c2c(C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)s1		CHEMBL3733268	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374451	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(OC(C)C)c(-c2c(C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)c1		CHEMBL3731018	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374753	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ncccc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728650	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374754	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1cc(Cl)ccc1OC(C)C		CHEMBL3731713	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374755	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C(C)(C)C)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3732117	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374756	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C(C)C)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731343	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374757	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCOc1ccc(Cl)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731000	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374758	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(C(F)(F)F)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731803	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374759	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ncccc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731778	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374760	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(OC)c(-c2c(C)sc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)c1		CHEMBL3730201	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374761	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1ccc(F)cc1-c1c(C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729166	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374762	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)c1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1-c1ccn[nH]1		CHEMBL3732623	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374763	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(-c2ccnn2C)sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3730216	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374764	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(NC(=O)C3CCCC3)csc12)Cc1ccccc1		CHEMBL3728774	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374765	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC(C)(C)C(=O)Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3731451	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374766	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC(C)(C)C(=O)Nc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728136	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374767	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12)C1CCCCC1		CHEMBL3728888	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374768	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(NC(=O)C3CCCCC3)csc12)Cc1ccccc1		CHEMBL3732190	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374769	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12)C1CCCC1		CHEMBL3728226	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374770	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(OC[C@H]3CCCN3)nc(-c3ccncc3)nc12		CHEMBL3733095	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374771	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	N[C@@H](COc1nc(-c2ccncc2)nc2c1sc1cccc(Cl)c12)Cc1ccccc1		CHEMBL3727569	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374772	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc2sc3c(OC[C@H]4CCCN4)nc(-c4ccncc4)nc3c12		CHEMBL3731450	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374773	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Clc1cccc2sc3c(OC[C@@H]4CCCN4)nc(-c4ccncc4)nc3c12		CHEMBL3729309	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374774	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(OC[C@@H]3CCCN3)nc(-c3ccncc3)nc12		CHEMBL3730892	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374775	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(OC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728292	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374776	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(OC[C@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3727858	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374777	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(O[C@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3728907	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374778	CHEMBL3734166	Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay	B	Cc1csc2c(O[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3732047	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374779	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Nc3ccccc3)csc12)Cc1ccccc1		CHEMBL3730660	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374780	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Nc3ccccn3)csc12)Cc1ccccc1		CHEMBL3728221	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374781	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(Nc2csc3c(N[C@@H]4CCNC4)nc(-c4ccncc4)nc23)nc1		CHEMBL3731054	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374782	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Nc3ncccn3)csc12)Cc1ccccc1		CHEMBL3728045	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374783	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Nc3ccncn3)csc12)Cc1ccccc1		CHEMBL3732053	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374784	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(Nc3ccon3)csc12)Cc1ccccc1		CHEMBL3729509	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374785	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(Nc3ccccc3)csc12)Cc1ccccc1		CHEMBL3731757	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374786	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cccc(Nc2csc3c(N[C@@H]4CCNC4)nc(-c4ccncc4F)nc23)c1		CHEMBL3729215	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374787	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1ccc(Nc2csc3c(N[C@@H]4CCNC4)nc(-c4ccncc4F)nc23)cc1		CHEMBL3731245	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374788	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnccc1-c1nc(N[C@@H]2CCNC2)c2scc(Nc3cccnc3)c2n1		CHEMBL3731471	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374789	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnccc1-c1nc(N[C@@H]2CCNC2)c2scc(Nc3ccccn3)c2n1		CHEMBL3728069	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374790	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(Nc2csc3c(N[C@@H]4CCNC4)nc(-c4ccncc4F)nc23)no1		CHEMBL3730446	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374791	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnccc1-c1nc(N[C@@H]2CCNC2)c2scc(Nc3ccon3)c2n1		CHEMBL3731423	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374792	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccccc1Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3F)nc12		CHEMBL3728087	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374793	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cccc(Nc2csc3c(N[C@@H]4CCNC4)nc(-c4ccncc4F)nc23)c1		CHEMBL3730120	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374794	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1ccccc1Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3F)nc12		CHEMBL3732486	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374795	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(C#CCCO)csc12)Cc1ccccc1		CHEMBL3727522	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374796	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1c(C#CC(C)(C)O)sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3729030	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374797	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc2c1C#CC(C)(C)O		CHEMBL3729218	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374798	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc2c1C#CC(C)(C)O		CHEMBL3733190	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374799	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)C#Cc1c(C(C)(C)C)sc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3733344	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374800	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(C#CCO)csc12)Cc1ccccc1		CHEMBL3728303	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374801	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2F)nc2c(C#CC3(O)CCC3)csc12)Cc1ccccc1		CHEMBL3730412	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374802	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3F)nc12		CHEMBL3729275	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374803	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3F)nc12		CHEMBL3732519	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374804	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730261	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374805	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730938	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374806	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CC3CC3)csc12)Cc1ccccc1		CHEMBL3727427	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374807	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728308	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374808	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)C#Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3727637	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374809	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CCO)csc12)Cc1ccccc1		CHEMBL3731337	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374810	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(N)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729896	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374811	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)C#Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3730328	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374812	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728744	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374813	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)C#Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3F)nc12		CHEMBL3728683	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374814	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COC(C)(C)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3732477	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374815	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729501	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374816	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC[C@@H](O)[C@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3732290	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374817	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@](C)(O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728039	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374818	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)[C@](C)(O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3727773	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374819	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC(O)(C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12)CC		CHEMBL3730568	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374820	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCC[C@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731640	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374821	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)C#Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3F)nc12		CHEMBL3729562	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374822	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CC3(O)CCCC3)csc12)Cc1ccccc1		CHEMBL3731776	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374823	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#Cc3ccccn3)csc12)Cc1ccccc1		CHEMBL3731386	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374824	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#Cc3ccccc3F)csc12)Cc1ccccc1		CHEMBL3730471	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374825	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CCCO)csc12)Cc1ccccc1		CHEMBL3732205	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374826	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CC3(O)CC3)csc12)Cc1ccccc1		CHEMBL3729862	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374827	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728627	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374828	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](O)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731704	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374829	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CCCCO)csc12)Cc1ccccc1		CHEMBL3727903	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374830	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(O)CC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3731236	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374831	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(O)CC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728004	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374832	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CNCC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730839	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374833	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CC3(O)CCC3)csc12)Cc1ccccc1		CHEMBL3728863	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374834	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)CC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729746	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374835	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728899	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374836	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3733296	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374837	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C#Cc1sc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc2c1C		CHEMBL3730528	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374838	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](F)C#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3727415	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374839	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CCF)csc12)Cc1ccccc1		CHEMBL3730419	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374840	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#CCCF)csc12)Cc1ccccc1		CHEMBL3733187	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374841	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3cn[nH]n3)csc12)Cc1ccccc1		CHEMBL3727484	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374842	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#Cc3cscn3)csc12)Cc1ccccc1		CHEMBL3727682	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374843	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C#Cc3cc[nH]n3)csc12)Cc1ccccc1		CHEMBL3732024	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374844	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)C(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3727409	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374845	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCCNC(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730158	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374846	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCN(CC)C(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730401	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374847	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CNC(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3730404	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374848	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCNC(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729854	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374849	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)NC(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729783	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374850	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(C(=O)NC3CC3)csc12)Cc1ccccc1		CHEMBL3730262	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374851	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)NC(=O)c1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3728817	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374852	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(/C=C/C(=O)O)csc12)Cc1ccccc1		CHEMBL3732295	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374853	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C#Cc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3731136	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374854	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N#Cc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3733028	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374855	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-n3cccn3)csc12)Cc1ccccc1		CHEMBL3732972	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374856	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-n3ccnn3)csc12)Cc1ccccc1		CHEMBL3729698	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374857	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(CCC3CC3)csc12)Cc1ccccc1		CHEMBL3732703	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374858	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2cc[n+]([O-])cc2)nc2c(Br)csc12)Cc1ccccc1		CHEMBL3732298	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374859	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2cc[n+]([O-])cc2)nc2c(-c3ccn[nH]3)csc12)Cc1ccccc1		CHEMBL3727554	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374860	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Nc1csc2c(NC[C@@H](N)Cc3ccccc3)nc(-c3ccncc3)nc12		CHEMBL3729527	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374861	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Nc1csc2c(N[C@@H]3CCNC3)nc(-c3ccncc3)nc12		CHEMBL3729586	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374862	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)no1		CHEMBL3729491	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374863	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)n[nH]1		CHEMBL3728980	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374864	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCc1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)no1		CHEMBL3728943	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374865	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CCc1cc(-c2csc3c(NC[C@@H](N)Cc4ccccc4)nc(-c4ccncc4)nc23)[nH]n1		CHEMBL3732216	<	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374866	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccncc2)nc2c(-c3ccon3)csc12)Cc1ccccc1		CHEMBL3729472	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374867	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)cc1		CHEMBL3732834	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374868	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccco1		CHEMBL3731611	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374869	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1ccccc1)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3727971	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374870	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=S(=O)(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3732666	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374871	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cnc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)cn1		CHEMBL3730828	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374872	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)[C@@H]1CCCO1		CHEMBL3731282	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374873	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnc(Nc2ccccc2)cc1-c1nc(N[C@@H]2CCNC2)c2sccc2n1		CHEMBL3730364	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374874	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1cnc(Nc2cnccn2)cc1-c1nc(N[C@@H]2CCNC2)c2sccc2n1		CHEMBL3732952	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374875	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)C(=O)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3729107	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374876	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)(C)NC(=O)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3728322	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374877	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CNC(=O)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3730634	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374878	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)N1CCCCC1		CHEMBL3732723	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374879	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1c(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccnc1Nc1cnccn1		CHEMBL3728398	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374880	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3729791	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374881	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3730334	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374882	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)nn1		CHEMBL3731525	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374883	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@H](Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3728040	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374884	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC[C@@H](Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3730659	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374885	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@H](O)CNc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3732375	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374886	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	C[C@@H](O)CNc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3731352	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374887	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O[C@@H](CNc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccccc1		CHEMBL3730161	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374888	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(NC2CC2)n1		CHEMBL3732862	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374889	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1cccs1		CHEMBL3729940	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374890	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	COc1cccc(C(=O)Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)c1		CHEMBL3731535	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374891	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(NCC2CC2)n1		CHEMBL3731860	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374892	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(CNc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)cc1		CHEMBL3730316	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374893	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)C1CC1		CHEMBL3729368	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374894	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)nc1		CHEMBL3729119	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374895	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1ccc(-c2ccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)nc2)cc1		CHEMBL3732659	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374896	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(Nc2ccc(N3CCOCC3)cn2)n1		CHEMBL3728881	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374897	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCN(c2ccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)nc2)CC1		CHEMBL3732541	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374898	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N#Cc1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)nc1		CHEMBL3729348	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374899	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCN(c2cccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)c2)CC1		CHEMBL3731806	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374900	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N#Cc1cccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)c1		CHEMBL3731598	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374901	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N#Cc1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)cc1		CHEMBL3733111	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374902	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(Nc2ccc(N3CCCCC3)cc2)n1		CHEMBL3732947	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374903	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)cc1		CHEMBL3730825	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374904	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(Nc2ccc(CN3CCCC3)cc2)n1		CHEMBL3727431	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374905	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)S(=O)(=O)c1cccc(Nc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)c1		CHEMBL3729210	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374906	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCN(C(=O)c2ccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)cc2)CC1		CHEMBL3727913	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374907	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cn(Cc2ccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)cc2)cn1		CHEMBL3730395	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374908	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1cnccn1		CHEMBL3729742	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374909	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1csc(-c2ccc(Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)cc2)c1		CHEMBL3727390	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374910	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(Nc2ccc(-c3ccsc3)cc2)n1		CHEMBL3728090	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374911	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccc(F)cc1		CHEMBL3728196	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374912	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Fc1c(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccnc1Nc1ccccc1		CHEMBL3732228	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374913	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4nc(N[C@@H]5CCNC5)c5sccc5n4)ccn3)cc2)CC1		CHEMBL3728075	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374914	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccc(N2CCOCC2)cc1		CHEMBL3728175	=	IC50	nM	100.0	CHEMBL2598	Homo sapiens	IC50	nM	100.0
	16374915	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=S(=O)(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)C1CC1		CHEMBL3728643	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374916	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(NC2CCCCC2)n1		CHEMBL3728675	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374917	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CS(=O)(=O)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3727635	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374918	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(NC2CCOCC2)n1		CHEMBL3729422	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374919	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CC(C)Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1		CHEMBL3730064	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374920	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	O=C(Nc1cc(-c2nc(N[C@H]3CNC[C@@H]3O)c3sccc3n2)ccn1)c1cccs1		CHEMBL3730182	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374921	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	CN1CC[C@@H](Nc2nc(-c3ccnc(NC(=O)c4cccs4)c3)nc3ccsc23)C1		CHEMBL3733148	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374922	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NC(=O)CN1C[C@H](O)[C@@H](Nc2nc(-c3ccnc(NC(=O)c4cccs4)c3)nc3ccsc23)C1		CHEMBL3729346	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374923	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	N[C@H](CNc1nc(-c2ccnc(NC(=O)c3cccs3)c2)nc2ccsc12)Cc1ccc(C(F)(F)F)cc1		CHEMBL3730235	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374924	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	NC(=O)CN1CC[C@@H](Nc2nc(-c3ccnc(Nc4ccccc4)c3)nc3ccsc23)C1		CHEMBL3728958	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374925	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	c1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)cc(Sc2cc(-c3nc(N[C@@H]4CCNC4)c4sccc4n3)ccn2)n1		CHEMBL3731080	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16374926	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1[nH]ncc1-c1nc(N[C@@H]2CCNC2)c2sccc2n1		CHEMBL3727560	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
	16374927	CHEMBL3734165	Inhibition of recombinant full-length human PKC-iota expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 150 uM ATP by fluorescence polarization based IMAP assay	B	Cc1[nH]ncc1-c1nc(NC[C@@H](N)Cc2ccccc2)c2sccc2n1		CHEMBL3730583	=	IC50	nM	1000.0	CHEMBL2598	Homo sapiens	IC50	nM	1000.0
	16413496	CHEMBL3742684	Inhibition of PKCiota (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	uM	10.0
	16431968	CHEMBL3750007	Inhibition of human PKCiota using [ERMRPRKRQGSVRRRV] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	uM	10.0
	16451577	CHEMBL3760874	Inhibition of PKCiota (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-1.5	CHEMBL2598	Homo sapiens	INH	%	-1.5
	16495190	CHEMBL3777518	Inhibition of N-terminal His6-tagged recombinant human PKCiota expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	4.0	CHEMBL2598	Homo sapiens	Activity	%	4.0
	16496109	CHEMBL3777518	Inhibition of N-terminal His6-tagged recombinant human PKCiota expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL2598	Homo sapiens	Activity	%	-3.0
	16508899	CHEMBL3777518	Inhibition of N-terminal His6-tagged recombinant human PKCiota expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL2598	Homo sapiens	Activity	%	5.0
	16614598	CHEMBL3815954	Inhibition of human PKCiota at 1 uM using [ERMRPRKRQGSVRRRV] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-15.0	CHEMBL2598	Homo sapiens	INH	%	-15.0
	16618115	CHEMBL3816501	Inhibition of full length recombinant human His-tagged PKC-iota expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	16837461	CHEMBL3876123	Inhibition of human recombinant full length His-tagged PRKCI expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	nM	10000.0
Inactive	17930592	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930593	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930594	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930595	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930596	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930597	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930598	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930599	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930600	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930601	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930602	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930603	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930604	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930605	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930606	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930607	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930608	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930609	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930610	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930611	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930612	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930613	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930614	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930615	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930616	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930617	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930618	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930619	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930620	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Active	17930621	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	51018.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	51018.0
Inactive	17930622	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930623	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930624	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930625	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930626	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930627	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930628	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930629	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930630	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930631	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930632	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930633	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930634	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930635	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930636	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930637	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930638	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930639	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930640	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930641	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930642	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930643	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930644	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930645	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930646	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930647	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930648	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930649	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930650	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930651	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930652	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930653	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930654	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930655	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930656	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930657	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930658	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930659	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930660	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930661	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930662	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930663	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930664	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930665	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930666	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930667	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930668	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930669	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930670	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930671	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930672	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930673	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930674	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930675	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930676	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930677	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930678	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930679	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930680	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930681	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930682	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930683	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930684	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930685	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930686	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930687	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930688	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930689	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930690	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930691	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930692	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930693	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930694	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930695	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930696	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930697	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930698	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930699	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930700	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930701	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930702	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930703	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930704	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930705	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930706	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930707	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930708	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930709	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930710	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930711	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930712	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930713	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930714	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930715	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930716	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930717	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930718	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930719	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930720	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930721	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930722	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930723	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930724	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930725	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930726	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930727	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930728	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930729	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930730	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930731	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930732	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930733	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930734	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930735	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930736	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930737	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930738	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930739	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930740	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930741	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930742	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930743	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930744	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930745	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930746	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930747	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930748	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930749	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930750	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930751	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930752	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930753	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930754	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930755	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930756	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930757	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930758	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930759	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930760	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930761	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930762	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930763	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930764	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930765	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930766	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930767	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930768	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930769	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Active	17930770	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	1230.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	1230.0
Inactive	17930771	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930772	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930773	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Active	17930774	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	27388.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	27388.0
Inactive	17930775	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930776	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930777	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930778	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930779	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930780	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930781	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930782	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930783	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930784	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930785	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930786	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930787	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930788	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930789	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930790	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930791	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930792	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930793	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930794	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930795	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930796	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930797	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930798	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930799	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930800	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930801	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930802	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930803	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930804	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930805	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930806	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930807	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930808	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930809	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930810	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930811	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930812	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930813	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930814	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930815	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930816	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930817	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930818	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930819	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930820	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930821	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930822	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930823	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930824	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930825	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Active	17930826	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	1982.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	1982.0
Inactive	17930827	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930828	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930829	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930830	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930831	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930832	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
Active	17930833	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	2422.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	2422.0
Inactive	17930834	CHEMBL3991846	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2598	Homo sapiens	Kd apparent	nM	30000.0
	18048603	CHEMBL4011051	Inhibition of TNFalpha-stimulated PKCI in human U937 cells assessed as residual activity at 10 uM in presence of ATP relative to control	B	S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4088718	=	Activity	%	106.0	CHEMBL2598	Homo sapiens	Activity	%	106.0
	18114811	CHEMBL4025341	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18153043	CHEMBL4034462	Inhibition of PKCi Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	8.5	CHEMBL2598	Homo sapiens	INH	%	8.5
	18203865	CHEMBL4044152	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18253517	CHEMBL4055042	Inhibition of recombinant human PKCiota (H215 to V587 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	85.0	CHEMBL2598	Homo sapiens	Activity	%	85.0
	18253518	CHEMBL4055042	Inhibition of recombinant human PKCiota (H215 to V587 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18265755	CHEMBL4057205	Inhibition of PKC-iota (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-6.7	CHEMBL2598	Homo sapiens	INH	%	-6.7
	18265991	CHEMBL4057441	Inhibition of PKC-iota (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.0	CHEMBL2598	Homo sapiens	INH	%	1.0
	18282773	CHEMBL4120358	Inhibition of PKC-iota (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-6.7	CHEMBL2598	Homo sapiens	INH	%	-6.7
	18283000	CHEMBL4120585	Inhibition of PKC-iota (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-7.0	CHEMBL2598	Homo sapiens	INH	%	-7.0
	18283166	CHEMBL4120751	Inhibition of PKC-iota (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-2.3	CHEMBL2598	Homo sapiens	INH	%	-2.3
	18327791	CHEMBL4135688	Inhibition of human wild type partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	CCc1ccc2nc(C(c3ccc(OC)c(OC)c3)n3cc(CCN4CCCCC4)nn3)sc2c1		CHEMBL4174041	=	Inhibition	%	40.0	CHEMBL2598	Homo sapiens	INH	%	40.0
	18440407	CHEMBL4157231	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18463791	CHEMBL4181207	Inhibition of recombinant human full length N-terminal His6-tagged PKCiota expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	11.0	CHEMBL2598	Homo sapiens	INH	%	11.0
	18484363	CHEMBL4186010	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	87.0	CHEMBL2598	Homo sapiens	Activity	%	87.0
	18484847	CHEMBL4186010	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	66.0	CHEMBL2598	Homo sapiens	Activity	%	66.0
	18502174	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Brc1ccnc2[nH]ccc12		CHEMBL4206553	=	IC50	nM	615000.0	CHEMBL2598	Homo sapiens	IC50	uM	615.0
	18502175	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cc1cnc2[nH]ccc2c1Cl		CHEMBL4204389	=	IC50	nM	452000.0	CHEMBL2598	Homo sapiens	IC50	uM	452.0
	18502176	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Oc1nncc2ccccc12		CHEMBL124706	=	IC50	nM	589000.0	CHEMBL2598	Homo sapiens	IC50	uM	589.0
	18502177	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cc1ccc(C)n1CCCn1ccnc1		CHEMBL4216587	=	IC50	nM	37000.0	CHEMBL2598	Homo sapiens	IC50	uM	37.0
	18502178	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Clc1ccnc2[nH]ccc12		CHEMBL4204893	=	IC50	nM	1300000.0	CHEMBL2598	Homo sapiens	IC50	uM	1300.0
	18502179	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Nc1ccc2[nH]cnc2c1		CHEMBL1617811	=	IC50	nM	728000.0	CHEMBL2598	Homo sapiens	IC50	uM	728.0
	18502180	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cn1ccc2cc(N)ccc21		CHEMBL4216063	=	IC50	nM	1312000.0	CHEMBL2598	Homo sapiens	IC50	uM	1312.0
	18502181	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	CNCc1ccc(-c2ccncc2)s1		CHEMBL4207793	=	IC50	nM	229000.0	CHEMBL2598	Homo sapiens	IC50	uM	229.0
	18502182	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	NC(=S)c1ccc2c(c1)CCO2		CHEMBL4212691	=	IC50	nM	927000.0	CHEMBL2598	Homo sapiens	IC50	uM	927.0
	18502183	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	O=C1CCCc2cc(O)ccc21		CHEMBL3288306	=	IC50	nM	1677000.0	CHEMBL2598	Homo sapiens	IC50	uM	1677.0
	18502184	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	CNc1ccc(C(C)=O)cc1N		CHEMBL4204735	=	IC50	nM	1423000.0	CHEMBL2598	Homo sapiens	IC50	uM	1423.0
	18502185	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Nc1ncccc1C(=O)Nc1ccccc1		CHEMBL4203838	=	IC50	nM	424000.0	CHEMBL2598	Homo sapiens	IC50	uM	424.0
	18502186	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	CCCc1ccc(O)c(C(C)=O)c1O		CHEMBL3274344	=	IC50	nM	1556000.0	CHEMBL2598	Homo sapiens	IC50	uM	1556.0
	18502187	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	CCN(CC)Cc1cc(N)ccc1O		CHEMBL4215993	=	IC50	nM	1570000.0	CHEMBL2598	Homo sapiens	IC50	uM	1570.0
	18502188	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	OCc1cccc(-c2ccncc2)c1		CHEMBL4211034	=	IC50	nM	2216000.0	CHEMBL2598	Homo sapiens	IC50	uM	2216.0
	18502189	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	NC(=O)c1ccnc2[nH]ccc12		CHEMBL4202835	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	18502190	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1ccc(-c2ccnc3[nH]ccc23)nc1		CHEMBL4214498	=	IC50	nM	374000.0	CHEMBL2598	Homo sapiens	IC50	uM	374.0
	18502191	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	NC(=O)c1cccc(-c2ccnc3[nH]ccc23)c1		CHEMBL4207181	=	IC50	nM	371000.0	CHEMBL2598	Homo sapiens	IC50	uM	371.0
	18502192	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Brc1cnn(-c2ccnc3[nH]ccc23)c1		CHEMBL4218913	=	IC50	nM	201000.0	CHEMBL2598	Homo sapiens	IC50	uM	201.0
	18502193	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3c(c2)NCCO3)c2cc[nH]c2n1		CHEMBL4210601	=	IC50	nM	148000.0	CHEMBL2598	Homo sapiens	IC50	uM	148.0
	18502194	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3nccn3n2)c2cc[nH]c2n1		CHEMBL4205739	=	IC50	nM	75000.0	CHEMBL2598	Homo sapiens	IC50	uM	75.0
	18502195	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	O=C1NCc2cc(-c3ccnc4[nH]ccc34)ccc21		CHEMBL4202899	=	IC50	nM	105000.0	CHEMBL2598	Homo sapiens	IC50	uM	105.0
	18502196	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc2ccc(-c3ccnc4[nH]ccc34)cc2cn1		CHEMBL4218133	=	IC50	nM	95000.0	CHEMBL2598	Homo sapiens	IC50	uM	95.0
	18502197	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccn3cncc3c2)c2cc[nH]c2n1		CHEMBL4206942	=	IC50	nM	221000.0	CHEMBL2598	Homo sapiens	IC50	uM	221.0
	18502198	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3nc[nH]c3c2)c2cc[nH]c2n1		CHEMBL4212132	=	IC50	nM	41000.0	CHEMBL2598	Homo sapiens	IC50	uM	41.0
	18502199	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3cc[nH]c3c2)c2cc[nH]c2n1		CHEMBL4211603	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	18502200	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cn1cnc2ccc(-c3ccnc4[nH]ccc34)cc21		CHEMBL4204387	=	IC50	nM	20000.0	CHEMBL2598	Homo sapiens	IC50	uM	20.0
	18502201	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cn1cnc2cc(-c3ccnc4[nH]ccc34)ccc21		CHEMBL4216057	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	18502202	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cc1nc2ccc(-c3ccnc4[nH]ccc34)cc2[nH]1		CHEMBL4204384	=	IC50	nM	215000.0	CHEMBL2598	Homo sapiens	IC50	uM	215.0
	18502203	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3ncn(C4CNC4)c3c2)c2cc[nH]c2n1		CHEMBL4203835	=	IC50	nM	188000.0	CHEMBL2598	Homo sapiens	IC50	uM	188.0
	18502204	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3ncn(C4CCNCC4)c3c2)c2cc[nH]c2n1		CHEMBL4208713	=	IC50	nM	9500.0	CHEMBL2598	Homo sapiens	IC50	uM	9.5
	18502205	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3ncn(C4CCCNC4)c3c2)c2cc[nH]c2n1		CHEMBL4216980	=	IC50	nM	7700.0	CHEMBL2598	Homo sapiens	IC50	uM	7.7
	18502206	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cncc(-n2cnc3ccc(-c4ccnc5[nH]ccc45)cc32)c1		CHEMBL4217980	=	IC50	nM	6000.0	CHEMBL2598	Homo sapiens	IC50	uM	6.0
	18502207	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1ccc(Cn2cnc3ccc(-c4ccnc5[nH]ccc45)cc32)nc1		CHEMBL4214403	=	IC50	nM	7500.0	CHEMBL2598	Homo sapiens	IC50	uM	7.5
	18502208	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	Cc1cccc(-n2cnc3ccc(-c4ccnc5[nH]ccc45)cc32)c1		CHEMBL4215555	=	IC50	nM	7000.0	CHEMBL2598	Homo sapiens	IC50	uM	7.0
	18502209	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	NCc1cccc(-n2cnc3ccc(-c4ccnc5[nH]ccc45)cc32)c1		CHEMBL4211820	=	IC50	nM	1100.0	CHEMBL2598	Homo sapiens	IC50	uM	1.1
	18502210	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	NCc1ccc(-n2cnc3ccc(-c4ccnc5[nH]ccc45)cc32)cc1		CHEMBL4205851	=	IC50	nM	800.0	CHEMBL2598	Homo sapiens	IC50	uM	0.8
	18502211	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc(CN)ccc1-n1cnc2ccc(-c3ccnc4[nH]ccc34)cc21		CHEMBL4208982	=	IC50	nM	120.0	CHEMBL2598	Homo sapiens	IC50	uM	0.12
	18502212	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3ccc(-c4ccnc5[nH]ccc45)cc31)CNC2		CHEMBL4213984	=	IC50	nM	48.0	CHEMBL2598	Homo sapiens	IC50	uM	0.048
	18502213	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3ccc(-c4ccnc5[nH]ccc45)nc31)CNC2		CHEMBL4212934	=	IC50	nM	65.0	CHEMBL2598	Homo sapiens	IC50	uM	0.065
	18502214	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3cnc(-c4ccnc5[nH]ccc45)cc31)CNC2		CHEMBL4208028	=	IC50	nM	30.0	CHEMBL2598	Homo sapiens	IC50	uM	0.03
	18502215	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnc3ccc(-c4ccnc5[nH]ccc45)nn13)CNC2		CHEMBL4214431	=	IC50	nM	4800.0	CHEMBL2598	Homo sapiens	IC50	uM	4.8
	18502216	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)nc13)CNC2		CHEMBL4211722	=	IC50	nM	110.0	CHEMBL2598	Homo sapiens	IC50	uM	0.11
	18502217	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnc3ccc(-c4ccnc5[nH]ccc45)cn13)CNC2		CHEMBL4206023	=	IC50	nM	570.0	CHEMBL2598	Homo sapiens	IC50	uM	0.57
	18502218	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC2		CHEMBL4216507	=	IC50	nM	6.5	CHEMBL2598	Homo sapiens	IC50	uM	0.0065
	18502219	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1ccc2c(c1)C(=O)N(c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)C2	Outside typical range	CHEMBL4203536	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	18502220	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CN(C(C)=O)C2		CHEMBL4215391	=	IC50	nM	38000.0	CHEMBL2598	Homo sapiens	IC50	uM	38.0
	18502221	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CN(C)C2		CHEMBL4206065	=	IC50	nM	5.0	CHEMBL2598	Homo sapiens	IC50	uM	0.005
	18502222	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNCC2		CHEMBL4202753	=	IC50	nM	2.8	CHEMBL2598	Homo sapiens	IC50	uM	0.0028
	18502223	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC(C)C2		CHEMBL4208685	=	IC50	nM	3.8	CHEMBL2598	Homo sapiens	IC50	uM	0.0038
	18502224	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC(CF)C2		CHEMBL4212424	=	IC50	nM	2.7	CHEMBL2598	Homo sapiens	IC50	uM	0.0027
	18502225	CHEMBL4189551	Inhibition of full-length N-terminal GST-fused human PKC-iota expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	c1cc(-c2ccc3ncn(-c4ccc5c(c4)CNC5)c3c2)c2cc[nH]c2n1		CHEMBL4215492	=	IC50	nM	290.0	CHEMBL2598	Homo sapiens	IC50	uM	0.29
	18507645	CHEMBL4191146	Inhibition of recombinant full-length human PKCiota at 1 uM using ERMRPRKRQGSVRRRV as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	5.0	CHEMBL2598	Homo sapiens	INH	%	5.0
	18653421	CHEMBL4230193	Inhibition of PKC-iota (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-3.0	CHEMBL2598	Homo sapiens	INH	%	-3.0
	18653422	CHEMBL4230193	Inhibition of PKC-iota (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL2598	Homo sapiens	INH	%	2.0
	18655325	CHEMBL4230910	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18674846	CHEMBL4235417	Inhibition of PKCiota (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL2598	Homo sapiens	Ki	nM	10000.0
Not Determined	18674847	CHEMBL4235417	Inhibition of PKCiota (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL2598	Homo sapiens	Ki		
	18674848	CHEMBL4235417	Inhibition of PKCiota (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL2598	Homo sapiens	Ki	nM	10000.0
	18726725	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413	=	Inhibition	%	27.6	CHEMBL2598	Homo sapiens	INH	%	27.6
	18726726	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)c(O)c1		CHEMBL4282089	=	Inhibition	%	14.85	CHEMBL2598	Homo sapiens	INH	%	14.85
	18726727	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3ccccc3Cl)C(c3ccccc3Cl)C2)cc1		CHEMBL4279940	=	Inhibition	%	30.5	CHEMBL2598	Homo sapiens	INH	%	30.5
	18726728	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3cccc(Cl)c3)C(c3cccc(Cl)c3)C2)cc1		CHEMBL4290590	=	Inhibition	%	29.0	CHEMBL2598	Homo sapiens	INH	%	29.0
	18726729	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3cccc(Cl)c3)C(c3ccc(Cl)cc3)C2)cc1		CHEMBL4290181	=	Inhibition	%	22.8	CHEMBL2598	Homo sapiens	INH	%	22.8
	18726730	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3cccc(Cl)c3)C2)cc1		CHEMBL4282313	=	Inhibition	%	18.6	CHEMBL2598	Homo sapiens	INH	%	18.6
	18726731	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1		CHEMBL4286763	=	Inhibition	%	24.94	CHEMBL2598	Homo sapiens	INH	%	24.94
	18726732	CHEMBL4259278	Inhibition of recombinant GST-fused PKCiota (unknown origin) expressed in HEK293 cells at 20 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma32P]ATP by phosphorimaging analysis relative to control	B	Oc1cccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)c1		CHEMBL4278844	=	Inhibition	%	9.3	CHEMBL2598	Homo sapiens	INH	%	9.3
	18751206	CHEMBL4263915	Inhibition of PKC-IOTA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL2598	Homo sapiens	INH	%	1.0
	18752162	CHEMBL4264499	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18858162	CHEMBL4308008	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	88.0	CHEMBL2598	Homo sapiens	Activity	%	88.0
Not Active	18883532	CHEMBL4312759	Activity at human PKCiota at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL2598	Homo sapiens	Activity		
	18892693	CHEMBL4314556	Inhibition of recombinant full-length human PKCiota assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.0	CHEMBL2598	Homo sapiens	Activity	%	105.0
	18919452	CHEMBL4322809	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCI (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	255.0	CHEMBL2598	Homo sapiens	Kd	nM	255.0
	18919640	CHEMBL4322809	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCI (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	314.0	CHEMBL2598	Homo sapiens	Kd	nM	314.0
	18938227	CHEMBL4327840	Inhibition of human PKCiota assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.2	CHEMBL2598	Homo sapiens	Activity	%	101.2
	18938228	CHEMBL4327840	Inhibition of human PKCiota assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.65	CHEMBL2598	Homo sapiens	Activity	%	100.65
	18938685	CHEMBL4328204	Inhibition of human PKCiota assessed as residual activity at 100 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2598	Homo sapiens	Activity	%	65.0
	18939069	CHEMBL4328568	Inhibition of human PKCiota using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	31.6	CHEMBL2598	Homo sapiens	IC50	10'-8M	3.16
	18958598	CHEMBL4333593	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	18964606	CHEMBL4335244	Inhibition of recombinant full-length human PKCiota assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	102.0	CHEMBL2598	Homo sapiens	Activity	%	102.0
	18964607	CHEMBL4335244	Inhibition of recombinant full-length human PKCiota assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	105.0	CHEMBL2598	Homo sapiens	Activity	%	105.0
	18972057	CHEMBL4337067	Inhibition of recombinant full-length human PKCiota assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	81.0	CHEMBL2598	Homo sapiens	Activity	%	81.0
Not Active	19040116	CHEMBL4352019	Inhibition of recombinant full-length human PKCiota at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2598	Homo sapiens	INH		
Active	19041246	CHEMBL4352507	Inhibition of human PKCiota at 10 uM using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2598	Homo sapiens	INH		
	19059787	CHEMBL4358088	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	94.0	CHEMBL2598	Homo sapiens	Activity	%	94.0
	19090351	CHEMBL4365925	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	49.0	CHEMBL2598	Homo sapiens	Activity	%	49.0
	19092078	CHEMBL4366552	Inhibition of human PKCiota at 100 nM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.31	CHEMBL2598	Homo sapiens	INH	%	-2.31
	19144804	CHEMBL4377820	Inhibition of recombinant full-length human PKCiota at 1 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-4.0	CHEMBL2598	Homo sapiens	INH	%	-4.0
	19146932	CHEMBL4378860	Inhibition of full-length recombinant human PKCiota at 10 uM using ERMRPRKRQGSVRRRV as substrate after 40 mins by in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	5.0	CHEMBL2598	Homo sapiens	INH	%	5.0
	19148001	CHEMBL4379229	Inhibition of recombinant full-length human PKCiota using ERMRPRKRQGSVRR as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2598	Homo sapiens	IC50	uM	10.0
	19159615	CHEMBL4382719	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	73.0	CHEMBL2598	Homo sapiens	Activity	%	73.0
	19191392	CHEMBL4389438	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	51.0	CHEMBL2598	Homo sapiens	INH	%	51.0
	19192101	CHEMBL4389915	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	54.0	CHEMBL2598	Homo sapiens	INH	%	54.0
	19200357	CHEMBL4391541	Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	19254352	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)nc1C(=O)Nc1ccncc1		CHEMBL4517782	=	IC50	nM	270.0	CHEMBL2598	Homo sapiens	IC50	uM	0.27
	19254353	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1C(=O)Nc1ccncc1		CHEMBL4471416	=	IC50	nM	340.0	CHEMBL2598	Homo sapiens	IC50	uM	0.34
	19254354	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	NC(=O)c1cccc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)c1		CHEMBL4450572	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254355	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	NCc1cccc(Cc2cnc(N)c(C(=O)Nc3ccncc3)c2)c1		CHEMBL4441139	=	IC50	nM	710.0	CHEMBL2598	Homo sapiens	IC50	uM	0.71
	19254356	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncc(-c2ccccc2)cc1C(=O)Nc1ccncc1		CHEMBL4440509	=	IC50	nM	32000.0	CHEMBL2598	Homo sapiens	IC50	uM	32.0
	19254357	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncc(Br)cc1C(=O)Nc1ccncc1		CHEMBL4566521	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254358	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccncc1Br		CHEMBL4459501	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254359	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccnc(Br)c1		CHEMBL4552099	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254360	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Cc1cc(NC(=O)c2nccnc2N)cc(C)n1		CHEMBL4450468	=	IC50	nM	263000.0	CHEMBL2598	Homo sapiens	IC50	uM	263.0
	19254361	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1cccc(C2CC2)c1		CHEMBL4540971	=	IC50	nM	42200.0	CHEMBL2598	Homo sapiens	IC50	uM	42.2
	19254362	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	CC(C)(C)c1cc(NC(=O)c2nccnc2N)ccn1		CHEMBL4547613	=	IC50	nM	24000.0	CHEMBL2598	Homo sapiens	IC50	uM	24.0
	19254363	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	CCc1cc(NC(=O)c2nccnc2N)ccn1		CHEMBL4520505	=	IC50	nM	19600.0	CHEMBL2598	Homo sapiens	IC50	uM	19.6
	19254364	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccnc2[nH]ccc12		CHEMBL4454756	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254365	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccc2[nH]ccc2c1		CHEMBL4584982	=	IC50	nM	34000.0	CHEMBL2598	Homo sapiens	IC50	uM	34.0
	19254366	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)NCc1ccncc1		CHEMBL4459301	>	IC50	nM	384000.0	CHEMBL2598	Homo sapiens	IC50	uM	384.0
	19254367	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccc(O)cc1		CHEMBL4446447	=	IC50	nM	76000.0	CHEMBL2598	Homo sapiens	IC50	uM	76.0
	19254368	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1cccnc1		CHEMBL4551875	=	IC50	nM	77000.0	CHEMBL2598	Homo sapiens	IC50	uM	77.0
	19254369	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1nccnc1C(=O)Nc1ccncc1		CHEMBL4450200	=	IC50	nM	23000.0	CHEMBL2598	Homo sapiens	IC50	uM	23.0
	19254370	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncccc1C(=O)Nc1ccncc1		CHEMBL4543879	=	IC50	nM	22000.0	CHEMBL2598	Homo sapiens	IC50	uM	22.0
	19254371	CHEMBL4402363	Inhibition of recombinant human full length N-terminal GST-fused PKCi (1 to 587 residues) expressed in baculovirus expression system using 5-FAM-RFARKGSLRQKNV as substrate measured after 60 mins by caliper microfluidic mobility shift assay	B	Nc1ncccc1C(=O)Nc1ccccc1		CHEMBL4203838	=	IC50	nM	424000.0	CHEMBL2598	Homo sapiens	IC50	uM	424.0
	19266573	CHEMBL4405523	Inhibition of wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2598	Homo sapiens	INH	%	50.0
	19276079	CHEMBL4408082	Inhibition of recombinant human full length PKCiota at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	5.0	CHEMBL2598	Homo sapiens	INH	%	5.0
	19476621	CHEMBL4479769	Inhibition of full-length recombinant human His-tagged PRKCI expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	1500.0	CHEMBL2598	Homo sapiens	IC50	nM	1500.0
	19476721	CHEMBL4479769	Inhibition of full-length recombinant human His-tagged PRKCI expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	6700.0	CHEMBL2598	Homo sapiens	IC50	nM	6700.0
	19476821	CHEMBL4479769	Inhibition of full-length recombinant human His-tagged PRKCI expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	37.0	CHEMBL2598	Homo sapiens	IC50	nM	37.0
	19476921	CHEMBL4479769	Inhibition of full-length recombinant human His-tagged PRKCI expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	720.0	CHEMBL2598	Homo sapiens	IC50	nM	720.0
	20600644	CHEMBL4603596	Inhibition of recombinant full length human His-tagged PRKCI expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2598	Homo sapiens	IC50	uM	100.0
	20681772	CHEMBL4623321	Inhibition of recombinant full-length human aPKCiota using CREBtide as substrate incubated for 3 hrs in presence of ATP by kinase Glo luminescent assay	B	NCC1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL4637651	=	IC50	nM	70.0	CHEMBL2598	Homo sapiens	IC50	uM	0.07
	20681774	CHEMBL4623323	Inhibition of recombinant full-length human aPKCiota in presence of ATP at Km concentration by radiometric assay	B	NCC1CCN(c2nc(-c3ccncc3)nc3sc4c(c23)CCCC4)CC1		CHEMBL4637651	=	IC50	nM	4080.0	CHEMBL2598	Homo sapiens	IC50	uM	4.08
Not Active	22417548	CHEMBL4672628	Inhibition of PKClambda phosphorylation in human BXPC-3 cells at 1 uM incubated for 4 hrs by Western blot analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675		Inhibition	%		CHEMBL2598	Homo sapiens	INH		
	22423317	CHEMBL4674234	Inhibition of human PKCiota using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	90.31	CHEMBL2598	Homo sapiens	Activity	%	90.31
	22423318	CHEMBL4674234	Inhibition of human PKCiota using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	85.92	CHEMBL2598	Homo sapiens	Activity	%	85.92
	22843603	CHEMBL4720589	Inhibition of human PKCiota using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	16.7	CHEMBL2598	Homo sapiens	IC50	10^-8M	1.67
	22843948	CHEMBL4720934	Inhibition of human PKCiota assessed as residual activity using ERMRPRKRQGSVRRRV as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.85	CHEMBL2598	Homo sapiens	Activity	%	93.85
	22844833	CHEMBL4721508	Inhibition of PKCiota (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	96.55	CHEMBL2598	Homo sapiens	Activity	%	96.55
	22952964	CHEMBL4766901	Inhibition of recombinant full-length human PKCiota assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	109.0	CHEMBL2598	Homo sapiens	Activity	%	109.0
	23122772	CHEMBL4805123	Inhibition of human PRKCI assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL2598	Homo sapiens	Activity	%	89.0
	23123467	CHEMBL4805711	Inhibition of human PRKCI assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	71.0	CHEMBL2598	Homo sapiens	Activity	%	71.0
	23123922	CHEMBL4806166	Inhibition of DNA-tagged human PRKCI assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	23125024	CHEMBL4806728	Inhibition of human PRKCI assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	23125025	CHEMBL4806728	Inhibition of human PRKCI assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2598	Homo sapiens	Activity	%	100.0
	23128473	CHEMBL4807966	Inhibition of PKCiota (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2598	Homo sapiens	Activity	%	75.0
	23128474	CHEMBL4807966	Inhibition of PKCiota (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2598	Homo sapiens	Activity	%	75.0
	23128475	CHEMBL4807966	Inhibition of PKCiota (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2598	Homo sapiens	Activity	%	75.0
Not Active	23317608	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	74.0	CHEMBL2598	Homo sapiens	% Control	%	74.0
Not Active	23318076	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	99.0	CHEMBL2598	Homo sapiens	% Control	%	99.0
Not Active	23318742	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23319226	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23319863	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23320338	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23321016	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	97.0	CHEMBL2598	Homo sapiens	% Control	%	97.0
Not Active	23321484	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23322114	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	78.0	CHEMBL2598	Homo sapiens	% Control	%	78.0
Not Active	23322582	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	80.0	CHEMBL2598	Homo sapiens	% Control	%	80.0
Not Active	23323271	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL2598	Homo sapiens	% Control	%	92.0
Not Active	23323739	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	89.0	CHEMBL2598	Homo sapiens	% Control	%	89.0
Not Active	23324106	CHEMBL4880725	PKCiota (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-7.0	CHEMBL2598	Homo sapiens	% inhibition	%	-7.0
Not Active	23324593	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	99.4	CHEMBL2598	Homo sapiens	% Control	%	99.4
Not Active	23325228	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	66.0	CHEMBL2598	Homo sapiens	% Control	%	66.0
Not Active	23325696	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23326343	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL2598	Homo sapiens	% Control	%	93.0
Not Active	23326811	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	98.0	CHEMBL2598	Homo sapiens	% Control	%	98.0
Not Active	23327511	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	81.0	CHEMBL2598	Homo sapiens	% Control	%	81.0
Not Active	23327979	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23328566	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	84.0	CHEMBL2598	Homo sapiens	% Control	%	84.0
Not Active	23329034	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	98.0	CHEMBL2598	Homo sapiens	% Control	%	98.0
Not Active	23329487	CHEMBL4881194	PKCiota (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	102.0	CHEMBL2598	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23329980	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	77.0	CHEMBL2598	Homo sapiens	% Control	%	77.0
Not Active	23330448	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	81.0	CHEMBL2598	Homo sapiens	% Control	%	81.0
Not Active	23331204	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23331672	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23332259	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23332725	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	80.4	CHEMBL2598	Homo sapiens	% Control	%	80.4
Not Active	23333443	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23334082	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23334550	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	87.0	CHEMBL2598	Homo sapiens	% Control	%	87.0
Not Active	23334943	CHEMBL4881565	PKCiota (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	18.0	CHEMBL2598	Homo sapiens	% inhibition	%	18.0
Not Active	23335529	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23335997	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23336624	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	98.0	CHEMBL2598	Homo sapiens	% Control	%	98.0
Not Active	23337092	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23337741	CHEMBL4882112	PRKCI Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL2598	Homo sapiens	% Ctrl	%	97.0
Not Active	23338173	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL2598	Homo sapiens	% Control	%	93.0
Not Active	23338641	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23339253	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23339721	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23340358	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23340826	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23341483	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23341951	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	83.0	CHEMBL2598	Homo sapiens	% Control	%	83.0
Not Active	23342567	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	92.0	CHEMBL2598	Homo sapiens	% Control	%	92.0
Not Active	23343035	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	84.0	CHEMBL2598	Homo sapiens	% Control	%	84.0
Not Active	23343665	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	87.0	CHEMBL2598	Homo sapiens	% Control	%	87.0
Not Active	23344133	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	80.0	CHEMBL2598	Homo sapiens	% Control	%	80.0
Not Active	23344771	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	73.0	CHEMBL2598	Homo sapiens	% Control	%	73.0
Not Active	23345344	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL2598	Homo sapiens	% Control	%	96.0
Not Active	23345812	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23346389	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	77.3	CHEMBL2598	Homo sapiens	% Control	%	77.3
Not Active	23346857	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	96.2	CHEMBL2598	Homo sapiens	% Control	%	96.2
Not Active	23347459	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23347949	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	85.5	CHEMBL2598	Homo sapiens	% Control	%	85.5
Not Active	23348528	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23348996	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23349583	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23350201	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23350669	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23351274	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23351742	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23352194	CHEMBL4882883	PRKCI (PKC iota) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.5124	CHEMBL2598	Homo sapiens	% Inhibition	%	-0.5124
Not Active	23352766	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	80.0	CHEMBL2598	Homo sapiens	% Control	%	80.0
Not Active	23353234	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23354116	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	82.0	CHEMBL2598	Homo sapiens	% Control	%	82.0
Not Active	23354584	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	68.0	CHEMBL2598	Homo sapiens	% Control	%	68.0
Not Active	23355316	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23355784	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23356420	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	89.0	CHEMBL2598	Homo sapiens	% Control	%	89.0
Not Active	23356888	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	83.0	CHEMBL2598	Homo sapiens	% Control	%	83.0
Not Active	23357497	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23358144	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	81.0	CHEMBL2598	Homo sapiens	% Control	%	81.0
Not Active	23358612	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	96.0	CHEMBL2598	Homo sapiens	% Control	%	96.0
Not Active	23359198	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23359796	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23360264	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	93.0	CHEMBL2598	Homo sapiens	% Control	%	93.0
Not Active	23360849	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL2598	Homo sapiens	% Control	%	94.0
Not Active	23361317	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23361890	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23362426	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23362894	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23364536	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	79.0	CHEMBL2598	Homo sapiens	% Control	%	79.0
Not Active	23365004	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23365743	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23366286	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	75.0	CHEMBL2598	Homo sapiens	% Control	%	75.0
Not Active	23366876	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	97.0	CHEMBL2598	Homo sapiens	% Control	%	97.0
Not Active	23367344	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23367709	CHEMBL4884062	PKC-iota ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	91.0	CHEMBL2598	Homo sapiens	% Residual activity with Skepinone-L	%	91.0
Not Active	23368222	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	98.0	CHEMBL2598	Homo sapiens	% Control	%	98.0
Not Active	23368690	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23369289	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23369757	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	79.0	CHEMBL2598	Homo sapiens	% Control	%	79.0
Not Active	23370203	CHEMBL4884445	PKCiota (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	97.0	CHEMBL2598	Homo sapiens	% residual kinase activity	%	97.0
Not Active	23370725	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL2598	Homo sapiens	% Control	%	82.0
Not Active	23371193	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	66.0	CHEMBL2598	Homo sapiens	% Control	%	66.0
Not Active	23372002	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	94.0	CHEMBL2598	Homo sapiens	% Control	%	94.0
Not Active	23372470	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
	23372864	CHEMBL4884829	PKCiota(PRKILGRD) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2598	Homo sapiens	pIC50		6.0
	23373273	CHEMBL4885120	PKCiota(PRKILGRD) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2598	Homo sapiens	pIC50		6.0
	23373629	CHEMBL4885406	PKCiota(PRKILGRD) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2598	Homo sapiens	pIC50		6.0
Not Active	23375349	CHEMBL4886331	protein kinase C, iota  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	3.0	CHEMBL2598	Homo sapiens	% inhibition	%	3.0
Not Active	23375897	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	98.0	CHEMBL2598	Homo sapiens	% Control	%	98.0
Not Active	23376365	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	86.0	CHEMBL2598	Homo sapiens	% Control	%	86.0
Not Active	23376942	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23377410	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	72.0	CHEMBL2598	Homo sapiens	% Control	%	72.0
Not Active	23378270	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL2598	Homo sapiens	% Control	%	85.0
Not Active	23378738	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	91.0	CHEMBL2598	Homo sapiens	% Control	%	91.0
Not Active	23379905	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23380373	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	87.0	CHEMBL2598	Homo sapiens	% Control	%	87.0
Not Active	23381067	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23381715	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2598	Homo sapiens	% Control	%	100.0
Not Active	23382183	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	87.0	CHEMBL2598	Homo sapiens	% Control	%	87.0
Not Active	23382807	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	84.0	CHEMBL2598	Homo sapiens	% Control	%	84.0
Not Active	23383275	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	55.0	CHEMBL2598	Homo sapiens	% Control	%	55.0
Not Active	23383954	CHEMBL4887561	PRKCI Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	105.0	CHEMBL2598	Homo sapiens	% Ctrl	%	105.0
Not Active	23384424	CHEMBL4888019	PKCiota(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.85	CHEMBL2598	Homo sapiens	% inhibition	%	5.85
Not Active	23384695	CHEMBL4888221	PRKCI (PKC iota) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	6.0	CHEMBL2598	Homo sapiens	% Inhibition	%	6.0
Not Active	23385190	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	72.0	CHEMBL2598	Homo sapiens	% Control	%	72.0
Not Active	23385657	CHEMBL4879914	KinomeScan assay: inhibition of PRKCI	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	76.0	CHEMBL2598	Homo sapiens	% Control	%	76.0
